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The apicomplexan Cryptosporidium is a protozoan parasite of humans and other 
mammals. Cryptosporidium species cause acute gastro-enteritis and diarrheal disease in 
healthy humans and animals, and cause life-threatening infection in immuno-compromised 
individuals such as people with AIDS. It has a one-host life cycle and invades intestinal 
epithelial cells causing diarrhea, or more rarely the pulmonary epithelium. 
Cryptosporidium carries out all the asexual reproductive stages like several other 
apicomplexans. Current annotation of this organism predicts it to contain 3884 genes of 
which only 1581 genes have predicted functions. By using a combination of bioinformatics 
   
 x 
analysis, biochemical evidence, and high-throughput data, a genome-scale metabolic 
model of Cryptosporidium hominis is being constructed. The current model is comprised 
of approximately 213 gene-associated enzymes involved in major metabolic pathways 
including carbohydrate, nucleotide, amino acid, and energy metabolism. The approach of 
constructing a genome-scale model provides a link between the genotype and the 
phenotypic behavior of the organism, making it possible to study and predict behavior 
based upon genome content.  This modeling approach provides an overview for evaluating 
missing components in a metabolic network and provides an analytical framework for 
interpreting data as more research becomes available. The goal of constructing this model 
is to systematically study and analyze various functional behaviors of C. hominis with 
respect to its stages in life cycle and pathogenicity. 
 
  1 
 
 
 
 
CHAPTER 1 INTRODUCTION 
 
 
 
1.1 Cryptosporidium 
Cryptosporidium is a protozoan parasite that belongs to the apicomplexa phylum. It 
causes acute gastroenteritis and diarrhea. Many outbreaks in United States occurred in 
water parks, community swimming pools and day care centers. Interest in the study of this 
parasite has increased in the last two decades especially after the outbreak of 
cryptosporidiosis in Milwaukee, Wisconsin in 1993 where approximately 403,000 people 
were affected. It was the largest waterborne disease outbreak documented in the history of 
United States (Kenzie et al., 1994). Transmission of Cryptosporidium occurs mainly 
through contact with the contaminated water (e.g., drinking and recreational water). It is 
resistant to chemical treatment of water, like chlorination, as it exists in the form of oocysts 
when outside the host cell and these oocysts pass through the filtration systems of the 
water supplies as well.  
The two most studied species, C. hominis and C. parvum, which differ in host 
range, genotype, and pathogenicity, are more relevant to humans. C.hominis infects only 
humans, whereas C. parvum also spreads in other mammals. (Xu et al., 2004). 
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Figure 1: Infection cycle and life cycle of Cryptosporidium (adapted from 
Cryptosporidiosis figure from Department of Health and Human Services) 
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1.1.1 Infection cycle and life cycle 
Cryptosporidium is transmitted be the fecal-oral route via the oocyst stage. These 
infections increase with close human-to-human contact and by contact with infected 
livestock, zoo animals, or companion animals (Fayer, 1997). 
Transmission of Cryptosporidium parvum and C. hominis occurs mainly through 
contact with contaminated water (e.g., drinking or recreational water) as shown in Figure 
1.  Sometimes it may also be transmitted by food sources, such as chicken salad.  Many 
outbreaks in the United States have occurred in water parks, community swimming pools, 
and day care centers.  Zoonotic and anthroponotic transmission of C. parvum and 
anthroponotic transmission of C. hominis occur through exposure to infected animals or 
exposure to water contaminated by feces of infected animals.   
The life cycle of Cryptosporidium, shown diagrammatically in Figure 1, is complex 
as it involves both sexual and asexual developmental stages. It begins upon the inhalation 
or the ingestion of sporulated oocysts, which is the only exogenous stage, containing 4 
sporozoites within a tough layered wall. It is excreted from the body of an infected host in 
the feces. Following ingestion (and possibly inhalation) by a suitable host, excystation 
occurs.  The sporozoites are released and infect the epithelial cells of the gastrointestinal 
tract or other tissues such as the respiratory tract. Here the parasites undergo asexual 
multiplication (schizogony or merogony stages) and then sexual multiplication 
(gametogony) producing microgamonts (male) and macrogamonts (female).  Upon 
fertilization of the macrogamonts by the microgametes, oocysts are developed that 
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sporulate in the infected host.  Two different types of oocysts are produced –  
! The thick-walled, which is commonly excreted from the host, and 
! The thin-walled oocyst, which is primarily involved in autoinfection.   
Oocysts are infective upon excretion, thus permitting direct and immediate fecal-
oral transmission. (Department of Health and Human Services; Thompson et al., 2005) 
 
Oocysts – Thick- as well as thin-walled oocysts are usually recovered from culture after 
5 days of inoculation. Approximately 80% of the oocysts formed after the completion of 
the life cycle are thick- walled oocysts, which are released from the host in the faeces if 
present in the gastrointestinal tract, or via aerosols or nasal secretions if present in the 
respiratory tract. However, about 20% of oocysts fails to form a thick oocyst wall and are 
thus known as thin-walled oocysts. Thin-walled oocysts are important in autoinfection 
through continuous recycling of sporozoites excysting from ruptures thin-walled oocysts. 
(Thompson et al., 2005) 
  
Sporozoites – are 5.2 X 1.2 !m in size and are characterized by having a comma shape 
with a rounded posterior end and a pointed tapered anterior end. They actively move 
inside the oocysts, excysting and exhibits gliding movement. (Thompson et al., 2005) 
 
1.1.2 Maintenance and amplification of Cryptosporidium 
Cryptosporidium species are not very well studied because culturing and 
amplification of the organism of a big challenge. One of the major objectives of many 
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laboratories is to amplify the parasite and develop reproducible models of infection to 
facilitate biological, pathological, immunological and molecular and drug evaluation 
studies. There are two ways by which Cryptosporidium can be amplified: in vivo, in animal 
models and in vitro using different cell lines.  
 
1.1.2.1 Challenges faced in vivo. 
The majority of in vivo infections have been carried out using the C. parvum cattle 
genotype. Experimental infections with C. parvum have been successfully established in a 
variety of domestic and laboratory animals, especially neonates, immunosuppressed or 
immunodeficient animals. But there is a high level of difference in infectivity for 
laboratory animals even between two closely related species of Cryptosporidium - C. 
parvum and C. hominis. C. parvum cattle genotype can readily infect mice and cattle 
whereas C.hominis does not infect them. (Peng et al., 1997) 
In summary, Cryptosporidium does not support the infection with multiple 
genotypes. Apart from this, the amplification of Cryptosporidium in animal models is 
labor-intensive, expensive beyond the budget of most of the laboratories, and will not 
support the growth of the parasite for long period of time. (Thompson et al., 2005) 
  
1.1.2.2 Challenges faced in vitro 
There are many factors that affect the development and proliferation of 
Cryptosporidium in culture. These include the excystation protocol, age and strain of 
parasite, stage and size of the inoculum, host cell types and maturity, and culture 
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conditions such as pH, medium supplements and atmosphere. (Thompson et al., 2005) 
Although, major improvements in culturing Cryptosporidium in vitro have 
occurred since 1984, infections could not be maintained for more than a few days and only 
asexual phases of the parasite life cycle could be consistently maintained for short periods. 
Efforts are going on in the direction to optimize the conditions for growth in order to 
increase the number of parasite stages produced and days to maintain the culture for longer 
period of time. (Thompson et al., 2005) 
 
1.1.3 Host-pathogen interaction - disease caused 
Cryptosporidium lives in the intestine of the infected humans and animals, is 
transmitted by ingestion of oocycsts, and completes its life cycle in a single host (Figure 
1). In healthy humans, the parasite is responsible for symptoms such as watery diarrhea, 
abdominal cramps or pain, dehydration, nausea, vomiting, fever, and weight loss. Its major 
impact has been among those with weakened immune systems, including, people with HIV 
or AIDS or Transplant recipients.  They may develop serious, chronic, and sometimes fatal 
version of the illness (P. Xu et al., 2004). There is no therapy available so far to treat 
patients suffering from cryptosporidiosis.  
The time from ingestion of oocysts to the appearance of clinical signs is between 2 
and 14 days. The first clinical signs associated with infection is, diarrhea, which may or 
may not be associated with abdominal cramping. Severity varies from continuous 
voluminous watery diarrhea to scant or intermittent diarrhea. Blood is infrequently 
observed in the stool. Other clinical signs include general malaise, fever, and fatigue, loss 
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of appetite, nausea and vomiting. Dehydration and weight loss are also direct result from 
the symptoms (Ramirez, et al., 2004).  
In immunocompetent host, clinical signs last for 10-14 days, but in the 
immunocompromised individuals they can persist for months to years. (Thompson et al., 
2005) 
 
It is of particular concern for four reasons: 
1. The oocyst is extremely resistant to disinfection and cannot be killed with routine 
water-disinfection procedures; 
2. The disease is not treatable with antibiotics; 
3. The mortality from infection in severely immunocompromised patients can be as 
high as 50-60%; and 
4. Animal and human fecal wastes are associated with transmission of the disease to 
humans. (Bates, 2007) 
 
1.1.4 Genome of Cryptosporidium hominis 
The parasite genome was sequenced in 2004 by Xu et al. describes that it has eight-
chromosome, approximately 9.2 mb genome size and contains an estimated 3994 genes. In 
silico reconstitution of C.hominis biochemical properties reveal that basic metabolic 
pathways are extremely streamlined. The parasite depends mainly on glycolysis for energy 
production. It supports both aerobic and anaerobic metabolism. However, it shows limited 
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biosynthetic pathways and mainly relies on transporters. Following figure from Xu et al. 
explains the major metabolic pathways inside the C.hominis. (Xu et al., 2004) 
 
 
 
Figure 2: Predicted metabolic network inside C.hominis on the basis of genome annotation 
(Xu et al., 2004) 
  
1.2 Systems Biology   
Genome Sequencing  has enabled us to determine the biological components that 
make up a cell or an organism. The new discipline of systems biology examines how these 
components interact and form networks and how the networks generate the whole cell 
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functions corresponding to observable phenotypes. The study of whole systems, with the 
inclusion of genomic, proteomic, metabolomic, and fluxomic data together, is termed 
Systems Biology (Figure 3). 
 
 
Figure 3: Several elements that describe an organism (Fong, 2008) 
 
This approach focuses on finding the relation between the genotype and phenotype 
of an organism by using a network model, permitting a better understanding of the cellular 
processes. Recently, many network models of various organisms have been constructed 
and validated for use in biological prediction including Bacillus subtilis, Escherichia coli, 
Saccharomyces cerevisiae, Human cardiac mitochondria and Human RBCs. (Joyce & 
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Palsson, 2007) 
 
1.2.1 Modeling approach - Constraint Based Modeling 
Bringing together all the potential biochemical reactions of an organism, builds up 
a network chart of metabolic pathways however, in the biological world, cells are 
subjected to various constraints from environmental, physiochemical, evolutionary, and 
regulatory sources. By incorporating metabolic reactions as well as other above-mentioned 
properties into the systemic network reconstruction, these models account for the 
constraints that restrict an organism’s phenotypic behavior. Apart from constraints that 
arise from network topology and stoichiometry, other constraints can be incorporated into 
these models, e.g. experimentally determined maximum enzyme fluxes, thermodynamic 
limitation, internal metabolic flux determinations, transcriptional regulation, etc. The 
constraint-based modeling approach helps distinguish the networks states that a system can 
achieve from those it cannot achieve rather than exactly predicting the network behavior. 
(Joyce & Palsson, 2007; Raghunathan et al., 2009)  
 
1.2.2 Mathematical algorithms used for optimization 
Once the model is ready in the mathematical form we use mathematical 
optimization algorithm to investigate the production capabilities and systemic properties of 
the metabolic network (Joyce & Palsson, 2007; Shlomi et al., 2008). 
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1.2.2.1  Linear programming algorithm - Flux Balance Analysis 
Flux Balance Analysis (FBA) is a type of analysis that imposes mass balance and 
flux capacity constraints on the network and uses an optimization procedure to find a 
steady-state flux distribution that maximizes the biomass yield of the cell without the need 
for measurement of kinetic parameters. FBA relies on Linear programming based 
optimization. We define an objective function of our network such as biomass production, 
byproduct secretion, ATP production, etc. and try to optimize that objective. Linear 
programming works on optimizing the flux distribution for the network model that 
maximizes the stated objective. (Raman & Chandra, 2009; Roberts et al., 2009) 
 
1.2.2.2 Mixed integer linear programming algorithm – MILP 
Another type of optimization algorithm that is used in model analysis is MILP. It is 
called so because it unlike FBA when we use this algorithm we get the results in terms of 
integer (-1, 0, 1) that denoting if the reaction is in active state or inactive state and also 
gives us the flux value of the reaction which may be any decimal value between -1000 to 
1000. The flux values are calculated from by linear programming as in FBA. 
MILP used in the current work is from Shlomi et al. and the basis for MILP is to 
optimize the agreement between the two sets of information used (the metabolic model and 
the proteomic or expression data). (Shlomi et al., 2008) 
In the ideal situation, the reactions that are expressed implies that the proteins 
coding for that specific reaction are active and the reactions that are inactive should mean 
that the proteins are inactive. In the biological world its not an ideal situation i.e. there is a 
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possibility that a specific protein is found in the system but reaction is still in affective 
because of other factors affecting it such as presence of substrate.  
To better understand the functioning of MILP consider the following figure where 
the region of interested is either the active state of reaction and protein or the inactive state 
of reaction and protein and the aim is to maximize the information related to these 2 
regions and minimize the false positive and negative region. 
 
 
Figure 4: Optimization through MILP algorithm aims at maximizing the information 
related to the shaded region where reactions and proteins are both found either active or 
inactive and reducing the other regions. Note: false negative is the region where the protein 
is found in the systems but the reaction is not present or active where as false positive 
denotes the case where protein is absent in the system but the reaction is still expressed. 
The region of false positive exists with the gene expression data where genes are highly 
expressed or lowly expressed and not with the proteomic data. 
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1.3 Metabolic modeling 
1.3.1 Introduction 
Detailed, comprehensive-modeling efforts led to the development of three types of 
networks: metabolic networks, transcriptional regulatory networks and signaling networks 
(Palsson, 2007). The most commonly reconstructed and used networks are the metabolic 
networks that integrate the biochemical interactions present in the organism. Genome 
annotation provides the basis for the initial prediction of metabolic enzymes and the 
preliminary genome-scale model. Figure 4 shows the major steps involved construction 
genome scale metabolic models. 
Metabolic network interacts with essentially all other cellular processes. The 
reconstruction of these processes and the integration of multiple networks will lead to the 
description of a comprehensive range of cellular functions. 
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Figure 5: Overall process of genome scale metabolic reconstruction (adapted from 
Palsson, 2007) 
 
 
The metabolic reconstruction requires mainly 4 steps: 
Step 1: Network reconstruction, i.e. obtaining the genome annotation of 
the target organism. Genome annotations are available at several only databases 
such as, IMG (Integrated Microbial Genome), EntrezGene, CMR (Comprehensive 
Microbial Resource), Genome Reviews (through EBI, European Bioinformatics 
Institute), etc. Also there are several organism specific sources of genome like 
EcoCyc for E.coli, SGD (Saccharomyces Genome Database), etc. 
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Other databases such as KEGG, MetaCyc, Transport DB can be used to 
provide metabolic and transport reaction that’s have been shown to occur in a range 
of organisms. (Feist, et al., 2009) 
 
Step 2: Refining the draft reconstruction. The draft reconstruction 
created in previous step needs to manually curated, ideally with the inputs from 
organism specific experts. This step of manual curation is labor intensive and 
sometimes tedious. Organism- specific databases, textbooks, primary publication, 
review articles, and experts familiar with the legacy data for an organism are the 
main sources of information for the manual curation step. These sources of 
information provide direct or indirect evidence for the inclusion of specific 
reactions in the metabolic reconstruction. (Feist et al., 2009) 
 
Step 3: Mathematical modeling and analysis of the network. Applying 
mathematical algorithm to the curated biochemical to perform simulations and 
analysis. Once the network was reconstructed, the list of metabolic reactions was 
transformed into a stoichiometric matrix (S), i.e., the mathematical representation 
of the reconstructed network. The S matrix dimensions are m x n, where m is the 
number of metabolites and n is the number of reactions. Each element Sij represents 
the stoichiometric coefficient of metabolite i in reaction j. If the metabolite in a 
particular reaction is a reactant, the coefficient is negative (the metabolite is 
consumed by the reaction); if it is a product, the coefficient is positive (the 
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metabolite is produced by the reaction). The S matrix was then used as the basis of 
further analysis, i.e., Flux Balance Analysis. FBA uses linear programming based 
optimization to identify a particular flux distribution distribution (a single point in 
the multidimensional space of possible metabolic behaviors) that optimizes a given 
metabolic objective (see Biomass Equation, below). The LP optimization problem 
is formulated as:  
 
Maximize Z,  
Subject to S "  v = 0,  
ai < vi < bi for all reactions i.  
 
Z is the objective function; for this study, Z was defined as the biomass 
equation. The second two statements are the flux constraints. S is the stoichiometric 
matrix defined above. Each reaction flux is subject to lower and upper bounds, as 
indicated (in cases where these are not known, ai and bi are set to some arbitrary 
numbers that exceed any feasible internal flux). The solution to this problem is an 
optimal flux distribution, v, a vector that contains flux values for each reaction in 
the network. The solution is optimal in the sense that it maximizes the flux through 
the objective Z.  
Mathematically, S is a transformation of the reaction flux vector, v, to a 
vector of time derivatives for each metabolite concentration:  
 
S " v = dx/dt. 
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Since the time constants for metabolic transients are fast (< tens of 
seconds), but the time constants for cell growth are long (hours to days), the 
metabolites can be considered as existing in a quasi-steady state (Joyce & Palsson, 
2007). This leads to the second equation of the LP optimization problem above. 
Because of the emphasis on steady states, assumptions regarding reaction kinetics 
are not needed. 
 
Biomass Equation:  In FBA, optimization is used to find a particular flux 
distribution that maximizes a given metabolic objective. Typical metabolic 
objectives chosen for optimization include maximization of ATP production, 
byproduct secretion, or biomass production. In our work, we chose to optimize 
for biomass production (Roberts et al., 2009). Biomass production is 
represented in our model by an additional metabolic reaction. Its reactants 
include such critical metabolites as ATP, acetyl-CoA, and NADPH; its products 
include ADP, inorganic phosphate, and other metabolites that represent 
byproducts of anabolic metabolism. 
 
Step 4: Integration of the high-throughput data. Further, the specific 
experimental or stage specific or tissue specific expression data or proteomic data 
is integrated with the existing comprehensive reconstructed metabolic network to 
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study the organisms’ performance with respect to the data and thus make further 
predictions. 
 
1.3.2 Application 
Such model once completed can be applied to study the specific growth condition 
from which the training data were based and can be used to explore additional 
environmental condition. Network reconstructions help us to build mechanistic genotype-
phenotype relationships and thus obtain quantitative (such as, what is the cellular growth 
rate) and qualitative (such as, will the organism grow in a particular condition) predictions 
about the organism. (Feist et al., 2009) 
In recent year with the growing popularity of the systems biology approach of 
solving biological problem, researchers from various fields have tried the metabolic 
reconstructs to analyze the target organism and explain the basis behind some of the 
previously discovered facts (de Figueiredo et al., 2008). Some of the important 
applications of metabolic model reconstruction include, optimization of production of 
certain metabolites (Hjersted & Henson, 2009), study host pathogen interaction 
(Raghunathan et al., 2009), studying single gene deletions (Xu, Sun, & Yu, 2009) or gene 
knock out screening (Plaimas et al., 2008) or identifying novel antimicrobial drugs targets 
(Lee et al., 2009).  
 
1.4 Parasite study and metabolic modeling 
In context of pathogenic organisms, a metabolic reconstruction has a potential to 
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plays important role in drug discovery. With the completion of genome projects of several 
parasites, there are efforts going on to make sense of that information in terms of genes, 
their products, interactions in growth and development and survival of parasite. (Wambua, 
Mcconkey, & Westhead, 2009) 
 
1.4.1 Predicting new drug targets 
Genomic information provides an accurate picture of the metabolic reactions that 
are present in the organism. With the analysis of essential reactions from the whole 
network we can predict the enzymes or transporters that might be viable targets for few 
new drug target. 
 
1.4.2 Comparative genomics of host and pathogen metabolism 
In the study for potential drug targets against the pathogens, one of the most area of 
study is the interaction between the host and pathogen. Many parasites are found to have 
lost pathways that are essential for free-living species. For example, Mycoplasm genitalium 
contains 580 genes (Suthers et al., 2009), C. parvum lacks Kreb’s cycle enzymes (Fayer, 
1997). Often, they depend on the host cell for these incomplete but required missing links. 
These kinds of interactions between host and pathogen can be compared and studied as 
potential targets to fight against parasitic disease. 
In the current project a metabolic model of parasite Cryptosporidium hominis is 
constructed and integrated with proteomic data, and analyzed to make further predictions.
  20 
 
 
CHAPTER 2 METHODS 
 
 
 
2.1 Reconstruction process – genome to metabolic network 
 The process of reconstructing the metabolic network of C.hominis is shown in Figure 
5.  The overall process is divided into 4 major steps:  
Step 1. Network reconstruction 
Step 2. Network refinement 
Step 3. Network analysis and simulation 
Step 4. Proteomic data integration 
 In brief, the reconstruction process starts with genome annotation that defines the list 
of functionally identifiable genes present in C.hominis (P. Xu et al., 2004). This serves as 
the basis for a set of possible reactions that are catalyzed by these annotated gene products 
(enzymes coded by genes). Tables 1 and 2 contain information on the online genome and 
pathway databases and key references used for the reconstruction process.  
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Figure 6: Summary for the C.hominis metabolic network reconstruction  
 
Database Link 
Genome Database: 
CSBC Cryptosporidium hominis research 
Integrated Microbial Genomes (IMG) 
 
http://www.hominis.mic.vcu.edu 
http://img.jgi.doe.gov 
Pathways and other databases 
KEGG  
Transport Classification database (TCDB) 
 
http://www.genome.jp/kegg/pathway.html 
http://www.tcdb.org/ 
Gene Protein Reaction (GPR) 
Uniprot 
 
 
ftp://ftp.genome.jp/pub/kegg/genes/organis
ms/cho/cho_xrefall.list 
Table 1. Online resources for the reconstruction of metabolic network of C. hominis 
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Table 2. Key references consulted additional to the online resources for the reconstruction 
of metabolic network of C. hominis  
 
2.2   Refining the model 
EC numbers from the genome annotation were used to look for all possible 
reactions catalyzed by each enzyme. This created the list of possible reactions in the 
model. Also the gene IDs were added to the model for each reaction to create Gene 
Protein Relation (GPR) files file for further usage. 
A list of metabolites required by the set of reactions was compiled within a Source 
file and also there was a compiled list of byproducts, as Escapes file were created with 
literature reviews of closely related species model available. These files were revised with 
data available for C.hominis experimental information and with simulation runs. Also, 
draft biomass equation was derived based on the existing equation for B. subtilis (Oh et al., 
2007), as qualitative results of FBA are relatively insensitive to minor mis-specification of 
the coefficient values. The goal is to eventually have experimental values for C.hominis. 
All these files contain necessary inputs for steady state operation and simulate the 
availability of certain metabolites in culture medium.  
 
Metabolism References 
Complete metabolism overview Thompson et al. 2005 
Carbohydrates  Thompson et al. 2005 
Energy Thompson et al. 2005 
Nucleic acid Thompson et al. 2005 
Amino acid  
Fatty acids  Fritzler et al. 2007 
Mazumdar et al. 2007 
Thompson et al. 2005 
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2.3 Analysis of network using Metmodel and FBA 
2.3.1 Gap analysis 
 The Python-based framework, Metmodel (Roberts & Buck, 2007) was used to build 
and analyze an initial genome scale model of metabolism of C.hominis. The model is 
stored in a series of text file. Metmodel uses these files as input, performs FBA and outputs 
the predicted fluxes for each reaction in the model, given a set of objective (biomass 
production). Some of the reactions were added after the first simulation run as the original 
network/annotation was found to have gaps.  
 
Gap filling, also known as filling pathway holes, is a procedure for including 
the reactions that might be important and necessary to complete certain 
pathway for which only one or two reactions are missing. Most of the time it is 
possible that these reaction are present in the organism but the enzymes 
responsible for these reactions are not annotated in the genome, as there are 
several hypothetical proteins that are yet to be studied for their function. There 
is a possibility that these hypothetical proteins might code for some of these 
missing reaction. 
 
2.3.2 Essential reaction 
 Metmodel also helped in finding the essential reaction, i.e. the subset of lethal 
reactions in the model. The steps of determining them were as follows: 
For each reaction, X:  
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1. Set the upper and lower bounds of reaction X to zero by setting up constrain on 
the reaction to have zero flux. This simulates the loss of reaction. 
2. Run FBA,  
! If objective value from FBA run comes out to be 0 (or ~ 0), the reaction is 
predicted to be lethal which means that there is no growth when the reaction 
is inactivated. 
! If not, then the reaction is predicted to be non-lethal, i.e. the parasite can 
still grow, even though reaction is inactivated. 
3. Reset the upper and lower bounds of reaction X to their original values. 
4. Continue to next reaction. 
  
2.4  Integrating the proteomic data with the model 
  As mentioned in the figure 1, parasite has a life cycle and the first two stages – 
oocysts and sporozoite were analyzed in terms of proteomic composition. Unpublished in-
house proteomic data that’s was used in this project describes the list of active proteins in a 
specific stage. This information was used to active or inactive the reactions in the model 
and see how the model will perform. This stage specific proteomic data was integrated 
with an optimization algorithm from Shlomi et. al (Shlomi et al., 2008).  
The graphical representation of the performance of metabolites in the 2 stages was 
shown using python based program designed in the laboratory. Figure 7 shows the 
graphical representation of the difference between the 2 stages. The following graph 
includes the metabolites that are used in highly different way in two stages. To draw this 
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chart, the difference in the conditions of both the stages was determined; all the 
metabolites involved in these conditions were listed. A score was assigned to these 
metabolites depending on the level of difference of usage of these metabolites in both the 
stages (i.e. highly different manner ~ highest score). Then the score was ranked and a 
threshold was set. To draw the final chart, the top list of metabolites was used. 
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 Figure 7: Graphical representation of comparative analysis of 2 stages oocyst and 
sporozoite in Cryptosporidium hominis depending upon the unpublished in-house proteomic 
data. Blue arrows shows oocyst stage activity and red arrows denote the sporozoite stage 
activity. This graphical representation only includes the reactions that show maximum level 
of difference only 
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CHAPTER 3 RESULTS 
 
 
 
3.1 Metabolic Reconstruction 
The iNV213 network reconstruction accounts for the function of 213 genes and 
includes 540 reactions with 514 metabolic reaction (including inter-conversion reactions of 
some metabolites) and 26 are extra-cellular transport reaction. Due to lack of direct 
biochemical evidences for many reactions, information from genomic data, literature 
derived conclusions and information from the related organism is used to evidences used to 
include these reaction in the model. Despite the fact that C. hominis is a Eukaryote, the 
current model contains only one intracellular compartment – the cytosol - as there is not 
much of information available in terms of compartments and specific pathways that take 
place inside of the organism. 
Figure 8 provides an overview of reactions of iNV213. Among, the pathways 
included in the model, carbohydrate metabolism seem the most functional metabolism 
network with glycolysis as one of the complete metabolic pathway. However, other 
metabolic network includes many reactions that are the inter-conversion reactions. 
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Figure 8: Reactions distribution in the model under several metabolic pathways. 
Miscellaneous reaction is the set of reactions that were required for the model but could 
not be categorized under specific metabolism network. Nucleotide metabolism, which is 
found to have maximum number of reaction in the network, actually comprises of multiple 
reactions that are coded by single enzymes but exact evidence could not be found to filter 
them and get the exact minimal set of reactions. Conclusively, carbohydrate metabolism 
was found to be the most functional and complete network in the model. After completion 
of reconstruction network a small set of reactions was added to the network to make it 
functional and yellow bars in each of the metabolic pathways highlights these reaction. 
 
Above figure shows the reaction distribution of each of the metabolic pathway. 
Genomic evidences support the completeness of metabolic networks such as, Energy 
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metabolism, glycan metabolism, metabolism of secondary products, and metabolism of 
other amino acids but some minor additions were required in the amino acid metabolism (3 
reactions), carbohydrate metabolism (3 reactions), and nucleotide metabolism (7 
reactions). Lipid metabolism accounts for 117 reactions with genomic evidence for 87 
reactions. Other 30 reactions were added through gap analysis to complete the metabolic 
network to of the organism. These reactions are explained in next section of gap analysis. 
 
 
Figure 9: Graphical representation of carbohydrate metabolism network that was found to 
be the active  
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3.2 Gap analysis – filling the missing links 
The next important step in completion of the model was filling up the missing links 
- the gaps. There were some of the reactions added to the original iNV213 after performing 
the FBA simulation. This process is termed as gap analysis in network modeling. These 
reactions are required in order to complete certain pathways e.g., lipid metabolism cannot 
be functional if these 30 reactions (Supplementary file 2) are absent in the network. 
Similarly, there is a small set of reaction added to many other pathways including fructose 
mannose metabolism, glycolysis / gluconeogenesis, aminosugar metabolism, tyrosine 
metabolism, extra-cellular transport reactions, valine, leucine and isoleucine biosynthesis, 
pyrimidine metabolism and purine metabolism. There is a set of 29 reactions added to the 
model through gap analysis but their exact sub systems were not studied. These reactions 
are listed in the supplement data file 2 but are not included in the following figure of gap 
analysis reactions chart. 
For some of these reaction filled in lipid metabolism by gap analysis, the enzymes 
responsible for them were further checked in genome of C. hominis. This was done by 
isolating the hypothetical protein sequences from the whole genome of C.hominis and 
performing the translated nucleotide BLAST against non-redundant protein sequences to 
see if there genome annotation can be updated after the developments since 2004 when this 
genome was last annotated. This might help us answer some of the questions about the 
reactions added through the gap analysis. At the current stage of this procedure, no 
significant matches were found but efforts are going on to optimize the search process. 
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Figure 9: Distribution of reactions added to the known metabolic networks by gap analysis algorithm. Almost 50% of the 
reactions are found to fill the gaps in lipid metabolism with most of the reaction in fatty acid biosynthesis, biosynthesis of 
steroids, glycerophospholipid metabolism and sphingolipid metabolism
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3.3 Essential reaction 
Simulation runs using Metmodel also helped in predicting the lethal reactions from 
the model. 52 reactions were found to be essential using the deletion prediction algorithm 
(described above). Summary of those lethal/essential reactions is shown in figure 10. 
When performing the iterative flux balance analysis to study for reaction deletions it was 
observed that eliminating reaction either reduces the optimal flux value or does not affects 
it at all. However, when any of these 52 reaction were removed or masked in the model the 
optimal flux value became negative which denotes there is no growth seen in the model if 
these reactions are absent from the pathway network.  
Figure 10 shows the lethal reaction distribution among the respective pathways. 
Individual analysis of each of these reactions and comparing them with the ones added 
through gap analysis showed that some of these reactions that were found lethal were 
added in the process of gap analysis eg. in the fatty acid metabolism, 16 reaction were 
found lethal out of which 9 reactions were added to the model by gap analysis algorithm. 
Also, among the 3 important reactions of the glycerophospholipid metabolism all of them 
were added in the above step to complete the metabolic network chart. Other predicted 
lethal reaction include 5 reactions (out of 10) were found to be lethal. This prediction is 
well supported by all the previous literature about importance of glycolysis in 
Cryptosporidium. Glycolysis is the fully functional and active pathway in the organism and 
the major source of energy production as well (Thompson et al., 2005). The lethal 
reactions found in glycolysis are listed in table 3.  
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Figure 10: Predicted number of essential reaction in the respective pathway. Green bars 
denote the lethal reactions found in each of the metabolic pathway where as the yellow bar 
shows the subset of those lethal reactions, which were included in the model by gap 
analysis algorithm 
 
Apart from these, other lethal reactions were from some of the amino acid 
metabolism (arginine and proline metabolism, glutamate metabolism), lipid metabolism 
(glycerolipid, and glycerophospholipid metabolism), NAD metabolism, and nucleotide 
metabolism.
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Table 3: Lethal reactions predicted in glycolysis and their function in the pathway (Ophardt, 2003)
Reaction 
number in 
Glycolysis 
Enzyme Reaction Function 
 
Reaction # 
4 
Fructose 
bisphosphate 
Split Molecule in half:  
fdp <==> dhap + g3p 
 
The six-carbon fructose diphophate is split into two 
three-carbon compounds, an aldehyde and a 
ketone. 
Reaction # 
5 
Glyceraldehyde-
3-phosphate 
dehydrogenase 
Oxidation/Phosphate Ester 
Synthesis: 
g3p + nad + pi <==> 13dpg + h + 
nadh 
 
This reaction is first an oxidation involving the 
coenzyme NAD+. The aldehyde is oxidized to an 
acid as an intermediate through the conversion of 
NAD+ to NADH + H+. Then an inorganic 
phosphate is added in a phosphate esteer synthesis. 
Reaction # 
7 
Phosphoglycero 
mutase 
Isomerization: 
2pg <==> 3pg 
 
In this reaction the phosphate group moves from 
the 3rd position to the 2nd position in an 
isomerization reaction. 
Reaction # 
8 
Enolase Alcohol Dehydration: 
2pg <==> h2o + pep 
In this reaction, which is the dehydration of an 
alcohol, the -OH on C-3 and the -H on C-2 are 
removed to make a water molecule. At the same 
time a double bond forms between C-2 and C-3. 
This change makes the compound somewhat 
unstable, but energy for the final step of glycolysis. 
Reaction # 
9 
Pyruvate kinase Phosphate Ester Hydrolysis; 
Synthesis of ATP: 
adp + h + pep --> atp + pyr 
 
This is the final reaction in glycolysis. Again one 
of the phosphate groups undergoes hydrolysis to 
form the acid and a phosphate ion, giving off 
energy. This first energy producing reaction is 
coupled with the next endothermic reaction making 
ATP. The phosphate is transferred directly to an 
ADP to make ATP. 
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3.4 Integrating the proteomic data 
Summary of integration of proteomic data with metabolic network can be found in 
the attached supplementary data file (Appendix D). Out of all the predicted reactions, it 
was found that 48 reactions were common between both the stages oocyst and sporozoite 
but 12 reactions were found to be present only in oocyst stage and 14 reactions were listed 
under sporozoite stage only. An important point to be noticed in the result was that 
glucokinase is active in sporozoite stage but not in oocyst stage on the other hand 
hexokinase is active in oocyst stage. Hexokinase in known to have more affinity for 
glucose where as glucokinase shows less affinity for glucose. This is justified observation 
as during the sporozoite stage when parasite if inside host cell it has sufficient supply of 
glucose and thus can afford to have active glucokinase activity where as when in oocyst 
stage the supply of glucose is not sufficient and thus hexokinase is active instead to make 
the carbohydrate metabolism work during minimal glucose concentration. Glucokinase 
activity can be rapidly amplified or damped in response to changes in the glucose supply.   
Graphical representation of difference in metabolite performance in 2 stages is shown in 
figure 7. 
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CHAPTER 4 DISCUSSION 
 
 
 
4.1 Model 
Previous research has shown that C. hominis relies mainly on glycolysis for its 
energy metabolism (Thompson et al., 2005; Zhu & Rider Jr, 2009). The current annotation 
of its genome, (P. Xu et al., 2004; Integrated microbial genome.) suggests the absence of 
several biosynthetic capabilities such as synthesis of major amino acids and nucleotides 
and appears to rely mainly on the extra cellular transport reactions (approximately 69 
proteins are annotated as transporters (P. Xu et al., 2004)). Nucleotide and amino acid 
includes salvage and inter-conversion pathways, but not the reactions for de novo synthesis 
since the parasite lacks that capability. Also, uptake of sugar, and amino acids in the model 
are facilitated by set transport reactions but the nucleotide and fatty acid uptake mechanism 
is not well understood and is therefore not completely discussed in the model. Fully 
functional glycolysis pathway as seen in iNV213 is supported by previous biochemical 
evidence (Fayer, 1997; Thompson et al., 2005; Zhu & Rider Jr, 2009), however some 
aspects of lipid in C. hominis are still not well understood. There is an ongoing analysis of 
the model to predict more such biochemical facts about the parasite to understand the 
   
 37 
systems better and develop new, testable hypotheses. 
 
4.2 Filling the gaps 
Cryptosporidium lacks many important links in the minimal set of metabolic 
pathway that is required for its successful replication and thus, the first simulation runs 
showed that the reconstructed model is incomplete and lacks some metabolic reactions. 
Resolving these metabolic gaps entails expanding the model by identifying and including 
missing biochemical activities. This process basically consists of two steps: (1) identifying 
plausible candidate reactions that could complete the model and (2) finding genes that 
could catalyze the hypothesized activities. The current work completes the filling of gaps 
however, finding gene for the hypothesized activity is one of the future directions for the 
project. 
Lipid metabolism was the metabolic network where most of the reactions were 
inserted to complete the reaction flow and get the optimal flux. These 30 reactions were in 
several categories respectively fatty acid metabolism, biosynthesis of steroids, 
glycerophospholipids, and shingolipids. Many previous and ongoing research suggest that 
these reactions, especially the glycerophosphlipids metabolism and biosynthesis of steroids 
are putative drug targets sites for apicomplexans. (Clastre et al., 2007; Ralph, D'Ombrain, 
& McFadden, 2001; Wambua et al., 2009) It is predicted that the reactions that are added 
through gap analysis in lipid metabolism might be the required reaction for completion of 
lipid metabolism but literature suggests that Cryptosporidium lacks the MEP pathway 
(Clastre et al., 2007) and therefore it can be predicted that they depend on the host cell for 
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these set of reaction. This opens up a prospect to individually analyze the subset of 
reaction added to the lipid metabolism to study the host – parasite interaction. As these 
reactions specially the ones added in glycerophospholipid mechanism are well-studied 
putative drug targets is other apicomplexans. Also, this information may be useful in 
determining minimal culture media requirement for the in vitro culturing of organism. 
 A noticeable addition to the glycerolipid pathways in this step was a phospholipase 
A2 catalyzed hydrolysis of phosphatidyl choline. However, there is a patent pending 
regarding use of phosphlipase A2 as biocides that neutralizes C. parvum sporozoite. 
(Homan, Imboden, Riggs, Carryn, & Schaefer, 2006) Thus, accuracy and eligibility of this 
addition of this reaction could not be established.  
In a recent review, Zhu et al. (2009) explain the lipid metabolism to a great extent 
but still there is no evidence for the biosynthetic capabilities of fatty acids in the C. 
hominis. But since these reactions are predicted to be required for the metabolic network to 
complete it might be possible that the parasite depends on host cell for some of these 
reactions. This finding again leads to these questions: If the parasite needs these reactions 
for the metabolic network to complete can any of its hypothetical proteins code for any of 
these reactions? If not, then is it possible to answer question related to the transport 
mechanism to support the entry of these lipids into the pathogen?  
To answer the first question, some of these functional proteins that coded for the 
newly added reaction were searched in the C. hominis genome. So far, no significant 
matches were found hence with the current understanding of model, no information could 
be added to the current genome annotation. This however opens up a prospect to perform 
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homology search for the specific proteins to reanalyze the subset of hypothetical proteins 
and also to study the transport mechanism of these lipids to update the list of transporter 
proteins in the parasite. 
Another interesting link added to the model was in amino sugar metabolism 
pathway. UDP acetylglucosamine epimerase catalyzes the reaction involving UDP-N-
acetyl-D-glucosamine. This reaction and enzyme is important in cyst-wall formation and 
Jarroll et al. suggest that this can be a putative drug target for cyst-walled protozoan. 
(Jarroll & Sener, 2003) 
 
4.3 Essential reactions 
The analysis of the essential reactions in the model is the most important outcome 
as this expected to determine the major potential drug target sites specific to C.hominis. 
From the subset of 52 reactions, Table 3 lists the 5 essential reactions of the glycolysis 
pathway, which accounts for almost 50% of the glycolysis reaction. But since glycolysis is 
an active pathway for all the host cells also, it does not prove to be a right direction to look 
for drug targets. An important extension of the work is to determine which of these lethal 
reactions are not affecting the human metabolic network. Attacking those sites might be 
useful in determining the weak link for the parasite.   
This reaction deletion approach can be used to find the performance of the cell in 
presence of enzyme inhibitors. Thus, if reaction X is predicted to be lethal, and an inhibitor 
of that enzyme is available, then the model can predict what will be the probability of 
growth of parasite in the presence of inhibitor. And this can be useful find the infection 
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neutralization chemicals (the enzyme inhibitors). 
 
4.4 From reaction deletion to gene knock out 
The ultimate aim of such model reconstruction is to extend the analysis to study 
gene knockout experiments in silico. The reaction deletion approach is useful to find out 
important reactions in the metabolic network. The GPR (Gene Protein Relation) file was 
used to study the relation of genes and proteins (enzymes) to determine which gene were 
important in the metabolism network of parasite.  
The supplement data file 3 provides the list of important genes that code for the 
lethal reactions in the metabolic network. These genes can be computationally switched on 
and off to study how the flux distribution would change in the presence or absence of a 
particular gene. Gene knockout experiments may again be useful to find putative drug 
targets for Cyrptosporidium. Some previous studies have shown how this approach can be 
made useful in predicting essential genes (Lee et al., 2009; Oh et al., 2007; Pinney et al., 
Nov 2007; Plaimas et al., 2008; Wambua et al., 2009). These genes will then be studied as 
potential drug targets that could be used to develop novel antibodies. 
 
4.5 Conclusion 
Genome-scale models integrate various types of data (genomic, expression and 
proteomic) and allow modeling of the integrated functions of an organism. It is a powerful 
tool that facilitates understanding of the whole system of an organism rather than focusing 
on a particular component or segment. This model-based study can be used to help 
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researchers prioritize experimental projects and save considerable time at the bench. 
Beyond serving as a tool for basic biological research, this computational approach also 
has potential medical and drug development relevance, e.g.: in pathogenic microbial 
models, each gene that is predicted to be essential by constraint based modeling and 
analysis, represents a potential drug target that could be used to develop novel antibiotics 
in future. Also, the network analysis of human biology may help us in detecting several 
therapeutic targets and thus provide a platform for assessing potentially adverse effects of 
novel treatments (Mo & Palsson, 2009). The flexibility of constraint-based models will 
lead to exploration of countless exciting biological questions in the future. 
 
   
 42 
 
 
CHAPTER 5 FUTURE DIRECTIONS 
 
 
 
5.1 Refining model 
There are lot of questions unanswered in terms of nucleotide metabolism, and lipid 
metabolism. The metabolic networks needs to be more refined with some more literature, 
biochemical or experimental evidences that individually focus on each of these reactions. 
For example, in nucleotide metabolism there are many enzymes that work in multiple ways 
and catalyze more than one reaction (in some cases around 20 reaction) but there were no 
evidences how so ever to include or exclude any of those multiple reaction. Similar cases 
were found in lipid metabolism as well. These reactions can be selected by studying the 
parasite specifically in terms of nucleotide and lipid composition. This question can be 
answered by some of the facts such as preference of substrate, behavior of organism under 
specific condition or stages.   
 
5.2 Finding the hypothesized function related gene 
With the gap analysis there are several hypothetical functions added to the 
metabolic network of the parasite. From the pool of hypothetical proteins these function 
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related genes could be determined. A specific enzyme codes each of the reaction added by 
gap analysis. If we can find out all the possible nucleotide sequence that may code for 
these protein and compare it with the hypothetical proteins of C.hominis it is possible that 
this may help to update the genome annotation for the organism 
 
5.3 Host pathogen interaction 
This pathogen depends on its host for various essential nutrients that support life, 
and experimental determination of its growth requirements has proven difficult. As seen in 
the gap analysis and essential reaction analysis there are several reactions related to lipid 
metabolism which suggest the presence of fatty acid, steroid, glycerolipid biosynthetic 
capabilities however, previous biochemical findings do not support this result. It might be 
possible that the pathogen uses the host cell’s biosynthetic capabilities for its survival in 
these cases. Analysis of this subset of reaction can be done in host cell to study how 
parasite might get this support of lipid metabolism to complete its growth requirement. 
This narrows down the list of reaction or pathways to focus on. 
  
5.4 Culturing condition optimization 
It is known that perfect culturing media composition could not be established for 
C.hominis growth (explained in section 1). From the gap analysis we have found some of 
the proteins that may be required by the organism but are not present in it. Experiments can 
be performed to see if addition of these enzymes in the culture media affects the growth in 
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some way. If the minimal media list can be derived by all these analysis it is possible to 
optimize its growth initially in silico then in vitro. 
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Appendices
Appendix A: Metabolic Network Reactions included in the Model iNV213
REACTION IDs GENE IDs EC NUMBER ENZYME NAME PATHWAY REACTION
R_BIOMASS . . biomass Biomass Equation [c] : 0.257980584 ala-L + 0.176597196 arg-L + 0.218152121 asn-L + 0.230278549 asp-L + 0.047389692 cys-L + 0.308171564 glu-L + 0.103857352 gln-L + 0.270219364 gly + 0.057785913 his-L + 0.343142715 ile-L + 0.350014856 leu-L + 0.327413561 lys-L + 0.101531685 met-L + 0.171391596 phe-L + 0.137139492 pro-L + 0.244438532 ser-L + 0.203965923 thr-L + 0.035839999 trp-L + 0.170934701 tyr-L + 0.287641274 val-L + 0.017366666 datp + 0.009566749 dctp + 0.009566749 dgtp + 0.017366666 dttp + 0.0394 ctp + 0.0003 cdp + 0.001 cmp + 0.0415 utp + 105.0535 atp + 0.0047 amp + 0.0674 gtp + 0.0002 gdp + 0.0005 gmp + 0.0009 ppi + 0.0162 nad + 0.0009 nadp + 0.0002 nadph + 0.008562798 m12dg_CT + 0.011044141 d12dg_CT + 0.006631063 t12dg_CT + 0.000458142 cdlp_CT + 0.017672003 pgly_CT + 0.002174587 lysylpgly_CT + 0.05622271 psetha_CT --> 105.0535 pi + 105.0535 h + 105.0509 adp
R_ALAR Chro.50329 5.1.1.1 alanineracemase Alanine and Aspartate Metabolism [c] : ala-L <==> ala-D
R_ASPTRS Chro.80047 or Chro.70182 or Chro.70181 or Chro.402676.1.1.12 Aspartyl-tRNAsynthetase Alanine and Aspartate Metabolism [c] : asp-L + atp + trnaasp --> amp + asptrna + ppi
R_ASNTRS Chro.80047 6.1.1.22 Asparaginyl-tRNAsynthetase Alanine and Aspartate Metabolism [c] : asn-L + atp + trnaasn --> amp + asntrna + ppi
R_ALATRS Chro.60075 6.1.1.7 Alanyl-tRNAsynthetase Alanine and Aspartate Metabolism [c] : ala-L + atp + trnaala --> alatrna + amp + ppi
R_PETHCT Chro.70332 2.7.7.14 phosphoethanolaminecytidyltransferase Aminophosphonate Metabolism [c] : ctp + ethamp + h --> cdpea + ppi
R_CHLP Chro.80135 2.7.7.15 cholinephosphatephosphatase Aminophosphonate Metabolism [c] : cholp + h2o --> chol + pi
R_CYANST Chro.40314 2.8.1.1 Cyanidesulfurtransferase Aminophosphonate Metabolism [c] : cyan + tsul --> h + so3 + tcynt
R_GF6PTA Chro.10420 2.6.1.16 glutamine-fructose-6-phosphatetransaminase Aminosugar Metabolism [c] : f6p + gln-L --> gam6p + glu-L
R_UDPACGLP Chro.40100 or Chro.70213 2.7.7.23 UDP-N-acetylglucosaminediphosphorylase Aminosugar Metabolism [c] : acgam1p + h + utp <==> ppi + udpacgal
R_UAGDP Chro.40100 or Chro.70213 2.7.7.23 UDP-N-acetylglucosaminediphosphorylase Aminosugar Metabolism [c] : acgam1p + h + utp --> ppi + uacgam
R_UAG4E . 5.1.3.7 R_UDP_N_acetylglucosamine_4_epimerase Aminosugar Metabolism [c] : 1.0 uacgam --> 1.0 uacgala
R_ACGAMPM Chro.40374 5.4.2.3 phosphoacetylglucosaminemutase Aminosugar Metabolism [c] : acgam6p <==> acgam1p
R_PROAKGOX1 Chro.30441 1.14.11.2 L-Proline,2-oxoglutarate:oxygenoxidoreductase(4-hydroxylating)(ER)Arg ine and Proline Metabolism [c] : akg + o2 + pro-L --> 4hpro-LT + co2 + succ
R_NOS2 Chro.40304 1.14.13.39 NitricOxideSynthase(NOforming) Arginine and Proline Metabolism [c] : nadph + 2 nwharg + 2 o2 --> 2 citr-L + h + 2 h2o + nadp + 2 no
R_NOS1 Chro.40304 1.14.13.39 NitricOxideSynthase(intermediateforming) Arginine and Proline Metabolism [c] : arg-L + h + nadph + o2 --> h2o + nadp + nwharg
R_3MOXTYROX Chro.21000 1.4.3.4 _3-Methoxytyramine:oxygenoxidoreductase(deaminating)Arginine and Proline Metabolism [c] : 3moxtyr + h2o + o2 --> 3mox4hpac + h2o2 + nh4
R_APRTO2 Chro.21000 1.4.3.4 N-acetylputrescine:oxygenoxireductase(deaminating) Arginine and Proline Metabolism [c] : aprut + h2o + o2 --> h2o2 + n4abutn + nh4
R_MHISOR Chro.21000 1.4.3.4 N-Methylhistamine:oxygenoxidoreductase(deaminating) Arginine and Proline Metabolism [c] : h2o + mhista + o2 --> 3mldz + h2o2 + nh4
R_MAOLNOR Chro.21000 1.4.3.4 monoamineoxidase(L-Normetanephrine) Arginine and Proline Metabolism [c] : h2o + normete-L + o2 --> 3m4hpga + h2o2 + nh4
R_4HGLSD Chro.70551 1.5.1.12 L-4-hydroxyglutamatesemialdehydedehydrogenase,mitochondrialArginine and Proline Metabolism [c] : 4hglusa + h2o + nad <==> e4hglu + 2 h + nadh
R_HPROym Chro.70551 1.5.1.12 L-hydroxyprolinedehydrogenase(NADP),mitochondrial Arginine and Proline Metabolism [c] : 4hpro-LT + nadp --> 1p3h5c + 2 h + nadph
R_PHCD Chro.70551 1.5.1.12 L-1-pyrroline-3-hydroxy-5-carboxylatedehydrogenase Arginine and Proline Metabolism [c] : 1p3h5c + 2 h2o + nad --> e4hglu + h + nadh
R_4HGLSDm Chro.70551 1.5.1.12 L-4-hydroxyglutamatesemialdehydedehydrogenase,mitochondrialArginine and Proline Metabolism [c] : 4hglusa + h2o + nad <==> e4hglu + 2 h + nadh
R_PYR5CDm Chro.70551 1.5.1.12 D1-pyrroline-5-carboxylatedehydrogenase,mitochondrial Arginine and Proline Metabolism [c] : glu5sa + h2o + nadp --> glu-L + 2 h + nadph
R_PUTA3 Chro.70551 1.5.1.12 puta3 Arginine and Proline Metabolism [c] : glu5sa + h2o + nad --> glu-L + 2 h + nadh
R_P5CR Chro.60426 1.5.1.2 pyrroline-5-carboxylatereductase Arginine and Proline Metabolism [c] : 1pyr5c + 2 h + nadph --> nadp + pro-L
R_HPROb Chro.60426 1.5.1.2 L-hydroxyprolinereductase(NADP) Arginine and Proline Metabolism [c] : 1p3h5c + 2 h + nadph --> 4hpro-LT + nadp
R_HPROa Chro.60426 1.5.1.2 L-hydroxyprolinereductase(NAD) Arginine and Proline Metabolism [c] : 1p3h5c + 2 h + nadh --> 4hpro-LT + nad
R_P5CRm Chro.60426 1.5.1.2 pyrroline-5-carboxylatereductase(m) Arginine and Proline Metabolism [c] : 1pyr5c + 2 h + nadph --> nadp + pro-L
R_P5CRx Chro.60426 1.5.1.2 pyrroline-5-carboxylatereductase Arginine and Proline Metabolism [c] : 1pyr5c + 2 h + nadh --> nad + pro-L
R_PRO1x Chro.60426 1.5.1.2 prolineoxidase(L-proline,NAD) Arginine and Proline Metabolism [c] : nad + pro-L --> 1pyr5c + 2 h + nadh
R_PROTRS Chro.60505 or Chro.80098 6.1.1.15 Prolyl-tRNAsynthetase Arginine and Proline Metabolism [c] : atp + pro-L + trnapro --> amp + ppi + protrna
R_ARGTRS Chro.50402 6.1.1.19 Arginyl-tRNAsynthetase Arginine and Proline Metabolism [c] : arg-L + atp + trnaarg --> amp + argtrna + ppi
R_DXPS . 2.2.1.7 _1-deoxy-D-xylulose5-phosphatesynthase Biosynthesis of Steroids [c] : g3p + h + pyr --> co2 + dxyl5p
R_CDPMEK . 2.7.1.148 _4-(cytidine5'-diphospho)-2-C-methyl-D-erythritolkinase Biosynthesis of Steroids [c] : 4c2me + atp --> 2p4c2me + adp + h
R_MEPCT . 2.7.7.60 _2-C-methyl-D-erythritol4-phosphatecytidylyltransferase Biosynthesis of Steroids [c] : 2me4p + ctp + h --> 4c2me + ppi
R_BACCL Chro.20303 6.3.4.15 biotin-[acetyl-CoA-carboxylase]ligase Biotin Metabolism [c] : atp + btn + h --> btamp + ppi
R_HACD1 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(acetoacetyl-CoA) Butanoate Metabolism [c] : aacoa + h + nadh <==> 3hbcoa + nad
R_HACD2 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(3-oxohexanoyl-CoA) Butanoate Metabolism [c] : 3ohcoa + h + nadh <==> 3hhcoa + nad
R_HACD3 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(3-oxooctanoyl-CoA) Butanoate Metabolism [c] : 3oocoa + h + nadh <==> 3hocoa + nad
R_HACD4 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(3-oxodecanoyl-CoA) Butanoate Metabolism [c] : 3odcoa + h + nadh <==> 3hdcoa + nad
R_HACD5 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(3-oxododecanoyl-CoA)Butanoate Metabolism [c] : 3oddcoa + h + nadh <==> 3hddcoa + nad
R_HACD6 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(3-oxotetradecanoyl-CoA)Butanoate Metabolism [c] : 3otdcoa + h + nadh <==> 3htdcoa + nad
R_HACD7 Chro.30048 1.1.1.35 _3-hydroxyacyl-CoAdehydrogenase(3-oxohexadecanoyl-CoA)Butanoate Metabolism [c] : 3ohdcoa + h + nadh <==> 3hhdcoa + nad
R_PGK Chro.70113 2.7.2.3 phosphoglyceratekinase Carbon Fixation [c] : 3pg + atp <==> 13dpg + adp
R_RPI Chro.10337 5.3.1.6 ribose-5-phosphateisomerase Carbon Fixation [c] : r5p <==> ru5p-D
R_OIVD1 1.2.4.4 R_2_oxoisovalerate_dehydrogenase__acylating_4_methyl_2_oxopentaoate_Cofactor a d Prosthetic Group Biosynthesis[c] : 1.0 4mop + 1.0 coa + 1.0 nad <==> 1.0 co2 + 1.0 ivcoa + 1.0 nadh
R_MECDPS . 4.6.1.12 _2-C-methyl-D-erythritol2,4-cyclodiphosphatesynthase Cofactor and Prosthetic Group Biosynthesis[c] : 2p4c2me --> 2mecdp + cmp
R_CYSTRS Chro.60125 6.1.1.16 Cysteinyl-tRNAsynthetase Cysteine Metabolism [c] : atp + cys-L + trnacys --> amp + cystrna + ppi
R_MCOATA Chro.40326 or Chro.30258 2.3.1.39 Malonyl-CoA-ACPtransacylase Fatty Acid  Biosynthesis [c] : ACP + malcoa <==> coa + malACP
R_KAS2 . 2.3.1.41 R_b_ketoacyl_synthetase__n_C140_ Fatty Acid  Biosynthesis [c] : 1.0 accoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 12.0 nadp + 1.0 ttdca
R_KAS8 . 2.3.1.41 R_b_ketoacyl_synthetase__palmitate__n_C160_ Fatty Acid  Biosynthesis [c] : 1.0 accoa + 20.0 h + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdca + 14.0 nadp
R_KAS13 . 2.3.1.41 R_b_ketoacyl_synthetase__n_C180_ Fatty Acid  Biosynthesis [c] : 1.0 accoa + 23.0 h + 8.0 malcoa + 16.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 16.0 nadp + 1.0 ocdca
R_KAS141 . 2.3.1.41 R_b_ketoacyl_synthetase__n_C141_ Fatty Acid  Biosynthesis [c] : 1.0 accoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 11.0 nadp + 1.0 ttdce
R_KAS7 . 2.3.1.41 R_b_ketoacyl_synthetase__n_C161_ Fatty Acid  Biosynthesis [c] : 1.0 accoa + 19.0 h + 7.0 malcoa + 13.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdcea + 13.0 nadp
R_KAS17 . 2.3.1.41 R_b_ketoacyl_synthetase__n_C181_ Fatty Acid  Biosynthesis [c] : 1.0 accoa + 22.0 h + 8.0 malcoa + 15.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 15.0 nadp + 1.0 ocdcea
R_KAS100iso . 2.3.1.41 R_b_ketoacyl_synthetase__branched(iso)_C100 Fatty Acid  Biosynthesis [c] : 8.0 h + 1.0 ibcoa + 3.0 malcoa + 6.0 nadph --> 3.0 co2 + 4.0 coa + 1.0 dca + 2.0 h2o + 6.0 nadp
R_KAS130iso . 2.3.1.41 R_b_ketoacyl_synthetase__branched(iso)_C130 Fatty Acid  Biosynthesis [c] : 11.0 h + 1.0 ivcoa + 4.0 malcoa + 8.0 nadph --> 4.0 co2 + 5.0 coa + 1.0 trdca + 3.0 h2o + 8.0 nadp
R_KAS1 . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C140_ Fatty Acid  Biosynthesis [c] : 14.0 h + 1.0 ibcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa1 + 4.0 h2o + 10.0 nadp
R_KAS3 . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C150_ Fatty Acid  Biosynthesis [c] : 14.0 h + 1.0 ivcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa3 + 4.0 h2o + 10.0 nadp
R_KAS6 . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C160_ Fatty Acid  Biosynthesis [c] : 17.0 h + 1.0 ibcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa6 + 5.0 h2o + 12.0 nadp
R_KAS11 . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C170_ Fatty Acid  Biosynthesis [c] : 17.0 h + 1.0 ivcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa11 + 5.0 h2o + 12.0 nadp
R_KAS180iso . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C180_ Fatty Acid  Biosynthesis [c] : 20.0 h + 1.0 ibcoa + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 1.0 ocdcaiso + 6.0 h2o + 14.0 nadp
R_KAS5 . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C161_ Fatty Acid  Biosynthesis [c] : 16.0 h + 1.0 ibcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa5 + 5.0 h2o + 11.0 nadp
R_KAS9 . 2.3.1.41 R_b_ketoacyl_synthetase__Iso_C171_ Fatty Acid  Biosynthesis [c] : 16.0 h + 1.0 ivcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa9 + 5.0 h2o + 11.0 nadp
R_KAS4 . 2.3.1.41 R_b_ketoacyl_synthetase__Anteiso_C150_ Fatty Acid  Biosynthesis [c] : 1.0 2mbcoa + 14.0 h + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa4 + 4.0 h2o + 10.0 nadp
R_KAS12 . 2.3.1.41 R_b_ketoacyl_synthetase__Anteiso_C170_ Fatty Acid  Biosynthesis [c] : 1.0 2mbcoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa12 + 5.0 h2o + 12.0 nadp
R_KAS10 . 2.3.1.41 R_b_ketoacyl_synthetase__Anteiso_C171_ Fatty Acid  Biosynthesis [c] : 1.0 2mbcoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa10 + 5.0 h2o + 11.0 nadp
R_ALCD19 Chro.80199 or Chro.80198 1.1.1.1 alcoholdehydrogenase(glycerol) Fatty Acid Metabolism [c] : glyald + h + nadh <==> glyc + nad
R_34DHOXPEGOX Chro.80199 or Chro.80198 1.1.1.1 _3,4-Dihydroxyphenylethyleneglycol:NAD+oxidoreductaseFatty Acid Metabolism [c] : 34dhmald + h + nadh <==> 34dhoxpeg + nad
R_LNS14DM Chro.21001 1.14.14.1 cytochromeP450lanosterol14-alpha-demethylase(NADP) Fatty Acid Metabolism [c] : 2 h + lanost + 3 nadph + 3 o2 --> 44mctr + for + 4 h2o + 3 nadp
R_MELATNOX Chro.21001 1.14.14.1 Melatonin:NADPoxidoreductase Fatty Acid Metabolism [c] : h + melatn + nadph + o2 --> 6hoxmelatn + h2o + nadp
R_FACOAL1813 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + elaid <==> amp + od2coa + ppi
R_FACOAL1812 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + vacc <==> amp + ppi + vacccoa
R_FACOAL150 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + ptdca <==> amp + ppi + ptdcacoa
R_FACOAL2042 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + eicostet <==> amp + eicostetcoa + ppi
R_FACOAL1831 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + lnlncg <==> amp + lnlncgcoa + ppi
R_FACOAL1832 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + lnlnca <==> amp + lnlncacoa + ppi
R_FACOAL241 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + nrvnc <==> amp + nrvnccoa + ppi
R_FACOAL170 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + hpdca <==> amp + hpdcacoa + ppi
R_FACOAL244_1 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + tettet6 <==> amp + ppi + tettet6coa
R_FACOAL182 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(octadecynoate) Fatty Acid Metabolism [c] : atp + coa + ocdcya <==> amp + ocdycacoa + ppi
R_FACOAL181 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(octadecenoate) Fatty Acid Metabolism [c] : atp + coa + ocdcea <==> amp + odecoa + ppi
R_FACOAL180 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(octadecanoate) Fatty Acid Metabolism [c] : atp + coa + ocdca <==> amp + ppi + stcoa
R_FACOAL184 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + strdnc <==> amp + ppi + strdnccoa
R_FACOAL141 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(tetradecenoate) Fatty Acid Metabolism [c] : atp + coa + ttdcea <==> amp + ppi + tdecoa
R_FACOAL140 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(tetradecanoate) Fatty Acid Metabolism [c] : atp + coa + ttdca <==> amp + ppi + tdcoa
R_FACOAL226i Chro.50052 or Chro.30084 6.2.1.3 C226fattyacidactivation Fatty Acid Metabolism [c] : atp + coa + crvnc --> amp + c226coa + ppi
R_FACOAL1822 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + lneldc <==> amp + lneldccoa + ppi
R_FACOAL1821 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + lnlc <==> amp + lnlccoa + ppi
R_FACOAL161 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(hexadecenoate) Fatty Acid Metabolism [c] : atp + coa + hdcea <==> amp + hdcoa + ppi
R_FACOAL160 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(hexadecanoate) Fatty Acid Metabolism [c] : atp + coa + hdca <==> amp + pmtcoa + ppi
R_FACOAL200 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : arach + atp + coa <==> amp + arachcoa + ppi
R_FACOAL203 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + dlnlcg <==> amp + dlnlcgcoa + ppi
R_FACOAL204 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : arachd + atp + coa <==> amp + arachdcoa + ppi
R_FACOAL205 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + tmndnc <==> amp + ppi + tmndnccoa
R_FACOAL206 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + phyt <==> amp + phytcoa + ppi
R_FACOAL226 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + crvnc <==> amp + c226coa + ppi
R_FACOAL224 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : adrn + atp + coa <==> adrncoa + amp + ppi
R_FACOAL240 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + lgnc <==> amp + lgnccoa + ppi
R_FACOAL260 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase(n-C26:0) Fatty Acid Metabolism [c] : atp + coa + hexc <==> amp + hexccoa + ppi
R_FACOAL245_2 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + tetpent3 <==> amp + ppi + tetpent3coa
R_FACOAL245_1 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + tetpent6 <==> amp + ppi + tetpent6coa
R_FACOAL191 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + prist --> amp + ppi + pristcoa
R_FACOAL246_1 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + tethex3 <==> amp + ppi + tethex3coa
R_FACOAL2251 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + coa + dcsptn1 <==> amp + dcsptn1coa + ppi
R_FACOAL2252 Chro.50052 or Chro.30084 6.2.1.3 fatty-acid--CoAligase Fatty Acid Metabolism [c] : atp + clpnd + coa <==> amp + clpndcoa + ppi
R_DHFR Chro.40506 1.5.1.3 dihydrofolatereductase Folate-Vit B9 Metabolism [c] : dhf + h + nadph <==> nadp + thf
R_FOLR2 Chro.40506 1.5.1.3 folatereductase Folate-Vit B9 Metabolism [c] : fol + nadph --> dhf + nadp
R_AKP1 Chro.70170 3.1.3.1 alkalinephosphatase(Dihydroneopterin) Folate-Vit B9 Metabolism [c] : ahdt + 3 h2o --> dhnpt + 2 h + 3 pi
R_HEX7 Chro.60435 2.7.1.1 hexokinase(D-fructose:ATP) Fructose and Mannose Metabolism [c] : atp + fru --> adp + f6p + h
R_HEX10 Chro.60435 2.7.1.1 hexokinase(D-glucosamine:ATP) Fructose and Mannose Metabolism [c] : atp + gam --> adp + gam6p + h
R_PFK26 Chro.50115 2.7.1.105 _6-phosphofructo-2-kinase Fructose and Mannose Metabolism [c] : atp + f6p --> adp + f26bp + h
R_MAN1PT Chro.20192 2.7.7.13 mannose-1-phosphateguanylyltransferase Fructose and Mannose Metabolism [c] : gtp + h + man1p --> gdpmann + ppi
R_MAN1PT2r . 2.7.7.22 mannose-1-phosphateguanylyltransferase(GDP)reversibleFructose and Mannose Metabolism [c] : gdp + h + man1p <==> gdpmann + pi
R_FBA4 Chro.10335 4.1.2.13 D-Fructose1-phosphateD-glyceraldehyde-3-phosphate-lyaseFructose and Mannose Metabolism [c] : xu1p-D <==> dhap + gcald
R_FBA5 Chro.10335 4.1.2.13 D-Tagatose1-phosphateD-glyceraldehyde-3-phosphate-lyaseFructose and Mannose Metabolism [c] : tag1p-D <==> dhap + glyald
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R_FBA2 Chro.10335 4.1.2.13 D-Fructose1-phosphateD-glyceraldehyde-3-phosphate-lyaseFructose and Mannose Metabolism [c] : f1p <==> dhap + glyald
R_FBA3 Chro.10335 4.1.2.13 Sedoheptulose1,7-bisphosphateD-glyceraldehyde-3-phosphate-lyaseFructose and Mannose Metabolism [c] : s17bp <==> dhap + e4p
R_TPI Chro.10337 5.3.1.1 triose-phosphateisomerase Fructose and Mannose Metabolism [c] : dhap <==> g3p
R_FCI Chro.20165 5.3.1.25 L-fucoseisomerase Fructose and Mannose Metabolism [c] : fuc-L <==> fcl-L
R_MAN6PI Chro.80224 5.3.1.8 mannose-6-phosphateisomerase Fructose and Mannose Metabolism [c] : man6p <==> f6p
R_PMANM Chro.40115 5.4.2.8 phosphomannomutase Fructose and Mannose Metabolism [c] : man1p <==> man6p
R_MALT Chro.30190 3.2.1.20 alpha-glucosidase Galactose metabolism [c] : h2o + malt --> 2 glc-D
R_UDPG4E Chro.40292 5.1.3.2 UDPglucose4-epimerase Galactose metabolism [c] : udpg <==> udpgal
R_P5CD Chro.60426 1.5.1.12 _1-pyrroline-5-carboxylatedehydrogenase Glutamate metabolism [c] : 1pyr5c + 2 h2o + nad --> glu-L + h + nadh
R_GLUTRS Chro.60505 or Chro.80098 or Chro.102446.1.1.17 Glutamyl-tRNAsynthetase Glutamate metabolism [c] : atp + glu-L + trnaglu --> amp + glutrna + ppi
R_GLNTRS Chro.10244 6.1.1.18 Glutaminyl-tRNAsynthetase Glutamate metabolism [c] : atp + gln-L + trnagln --> amp + glntrna + ppi
R_GMPS2 Chro.50499 6.3.5.2 GMPsynthase Glutamate metabolism [c] : atp + gln-L + h2o + xmp --> amp + glu-L + gmp + 2 h + ppi
R_G6PDH3 Chro.40088 or Chro.60425 1.1.1.49 glucose6-phosphatedehydrogenase(F420-Dependent) Glutathione Metabolism [c] : f420-2 + g6p --> 6pgl + f420-2h2
R_G6PDH2r Chro.40088 or Chro.60425 1.1.1.49 glucose6-phosphatedehydrogenase Glutathione Metabolism [c] : g6p + nadp <==> 6pgl + h + nadph
R_GTHP Chro.30063 1.11.1.9 glutathioneperidoxase Glutathione Metabolism [c] : 2 gthrd + h2o2 <==> gthox + 2 h2o
R_AMPTASECG Chro.80395 3.4.11.2 alanylaminopeptidase(cys-gly) Glutathione Metabolism [c] : cgly + h2o --> cys-L + gly
R_G3PD1ir Chro.20028 1.1.1.8 glycerol-3-phosphatedehydrogenase(NAD) Glycerolipid Metabolism [c] : dhap + h + nadh --> glyc3p + nad
R_G3PD6 Chro.80050 1.1.99.5 glycerol-3-phosphatedehydrogenase(menaquinone-8) Glycerolipid Metabolism [c] : glyc3p + mqn8 --> dhap + mql8
R_G3PD7 Chro.80050 1.1.99.5 glycerol-3-phosphatedehydrogenase(demethylmenaquinone-8)Glycerolipid Metabolism [c] : 2dmmq8 + glyc3p --> 2dmmql8 + dhap
R_G3PD5 Chro.80050 1.1.99.5 glycerol-3-phosphatedehydrogenase(ubiquinone-8) Glycerolipid Metabolism [c] : glyc3p + q8 --> dhap + q8h2
R_GPAM_hs Chro.60161 2.3.1.15 glycerol-3-phosphateacyltransferase Glycerolipid Metabolism [c] : Rtotalcoa + glyc3p --> alpa_hs + coa
R_AGPAT1 Chro.80165 2.3.1.51 _1-acylglycerol-3-phosphateO-acyltransferase1 Glycerolipid Metabolism [c] : Rtotal2coa + alpa_hs --> coa + pa_hs
R_DAGK_SA Chro.80280 2.7.1.107 Diacylglycerolkinase Glycerolipid Metabolism [c] : 0.02 12dgr_SA + atp --> adp + h + 0.02 pa_SA
R_DAGK_EC Chro.80280 2.7.1.107 Diacylglycerolkinase Glycerolipid Metabolism [c] : 0.02 12dgr_EC + atp --> adp + h + 0.02 pa_EC
R_CHOLK Chro.30240 2.7.1.32 Cholinekinase Glycerolipid Metabolism [c] : atp + chol --> adp + cholp + h
R_ETHAK Chro.50319 2.7.1.82 Ethanolaminekinase Glycerolipid Metabolism [c] : atp + etha --> adp + ethamp + h
R_EPCTX Chro.70332 2.7.7.14 ethanolamine-phosphatecytidylyltransferase Glycerolipid Metabolism [c] : 2ameph + ctp + h --> cmp2amep + ppi
R_CHLPCTD Chro.80135 2.7.7.15 cholinephosphatecytididyltransferase Glycerolipid Metabolism [c] : cholp + ctp + h --> cdpchol + ppi
R_CPCTDTX Chro.80135 2.7.7.15 choline-phosphatecytidylyltransferase Glycerolipid Metabolism [c] : ctp + h + ntm2amep --> cmpntm2amep + ppi
R_DASYNm_SC Chro.70059 or Chro.20170 2.7.7.41 CDP-Diacylglycerolsynthetase,yeast-specific,mitochondrialGlycerolipid Metabolism [c] : ctp + h + 0.01 pa_SC <==> 0.01 cdpdag_SC + ppi
R_DASYN_HP Chro.70059 or Chro.20170 2.7.7.41 CDP-DiacylglycerolsynthetaseHpspecific Glycerolipid Metabolism [c] : ctp + h + pa_Hp <==> cdpdag_HP + ppi
R_CDGGGS Chro.70059 or Chro.20170 2.7.7.41 CDP-2,3-di-O-geranylgeranyl-sn-glycerolsynthase Glycerolipid Metabolism [c] : ctp + dgggp + h --> cdgggp + ppi
R_DASYN_TC Chro.70059 or Chro.20170 2.7.7.41 CDP-Diacylglycerolsynthetase,cruzi-specific Glycerolipid Metabolism [c] : ctp + h + 0.01 pa_TC <==> 0.01 cdpdag_TC + ppi
R_CDSm Chro.70059 or Chro.20170 2.7.7.41 phosphatidatecytidylyltransferase Glycerolipid Metabolism [c] : ctp + h + pa_hs --> cdpdag_hs + ppi
R_DASYN_EC Chro.70059 or Chro.20170 2.7.7.41 CDP-Diacylglycerolsynthetase(Ecoli) Glycerolipid Metabolism [c] : ctp + h + 0.02 pa_EC <==> 0.02 cdpdag_EC + ppi
R_DASYN_SC Chro.70059 or Chro.20170 2.7.7.41 CDP-Diacylglycerolsynthetase,yeast-specific Glycerolipid Metabolism [c] : ctp + h + 0.01 pa_SC <==> 0.01 cdpdag_SC + ppi
R_DASYN_SA Chro.70059 or Chro.20170 2.7.7.41 CDP-Diacylglycerolsynthetase(Saureus) Glycerolipid Metabolism [c] : ctp + h + 0.02 pa_SA <==> 0.02 cdpdag_SA + ppi
R_DASYNm_TC Chro.70059 or Chro.20170 2.7.7.41 CDP-Diacylglycerolsynthetase,cruzi-specific,mitochondrialGlycerolipid Metabolism [c] : ctp + h + 0.01 pa_TC <==> 0.01 cdpdag_TC + ppi
R_CDS Chro.70059 or Chro.20170 2.7.7.41 phosphatidatecytidylyltransferase Glycerolipid Metabolism [c] : ctp + h + pa_hs --> cdpdag_hs + ppi
R_ETHAPT_TC Chro.40314 2.7.8.1 Ethanolaminephosphotransferase,cruzi-specific Glycerolipid Metabolism [c] : 0.01 12dgr_TC + cdpea <==> cmp + h + 0.01 pe_TC
R_PEPT_EC Chro.40314 2.7.8.1 ethanolaminephosphotransferase Glycerolipid Metabolism [c] : cmp + h + 0.02 pe_EC <==> 0.02 12dgr_EC + cdpea
R_ETHAPT_SC Chro.40314 2.7.8.1 Ethanolaminephosphotransferase,yeast-specific Glycerolipid Metabolism [c] : 0.01 12dgr_SC + cdpea <==> cmp + h + 0.01 pe_SC
R_PEPT_HP Chro.40314 2.7.8.1 ethanolaminephosphotransferase Glycerolipid Metabolism [c] : cmp + h + pe_HP <==> 12dgr_HP + cdpea
R_PINOS_TC Chro.80072 2.7.8.11 phosphatidylinositolsynthase,cruzi-specific Glycerolipid Metabolism [c] : 0.01 cdpdag_TC + inost --> cmp + h + 0.01 ptd1ino_TC
R_PGPPT Chro.80072 2.7.8.11 phosphatidyl-CMP:glycerophosphatephosphatidyltransferaseGlycerolipid Metabolism [c] : cdpdag_hs + glyc3p --> cmp + h + pgp_hs
R_PINOS_SC Chro.80072 2.7.8.11 phosphatidylinositolsynthase,yeast-specific Glycerolipid Metabolism [c] : 0.01 cdpdag_SC + inost --> cmp + h + 0.01 ptd1ino_SC
R_CDIPTr Chro.80072 2.7.8.11 phosphatidylinositolsynthase(Homosapiens) Glycerolipid Metabolism [c] : cdpdag_hs + inost <==> cmp + h + pail_hs
R_CDGGIPT Chro.80072 2.7.8.11 CDP-digeranyl-sn-glycero-myo-inositol3-phosphatidyltransferaseGlycerolipid Metabolism [c] : cdgggp + inost --> cmp + dggpi + h
R_PSSA1_hs Chro.10133 2.7.8.8 Phosphatidylserinesynthasehomosapiens Glycerolipid Metabolism [c] : pchol_hs + ser-L <==> chol + ps_hs
R_PSSA_HP Chro.10133 2.7.8.8 PhosphatidylserinesynthaseHpspecific Glycerolipid Metabolism [c] : cdpdag_HP + ser-L <==> cmp + h + ps_HP
R_CDGGGSAT Chro.10133 2.7.8.8 CDP-2,3-di-O-geranylgeranyl-sn-glyceroserineO-archaetidyltransferaseGlycerolipid Metabolism [c] : cdgggp + ser-L --> cmp + dgggps + h
R_PSSA_SA Chro.10133 2.7.8.8 Phosphatidylserinesyntase(Saureus) Glycerolipid Metabolism [c] : 0.02 cdpdag_SA + ser-L <==> cmp + h + 0.02 ps_SA
R_PSSA2_hs Chro.10133 2.7.8.8 Phosphatidylserinesynthasehomosapiens Glycerolipid Metabolism [c] : pe_hs + ser-L <==> etha + ps_hs
R_PSERS_SC Chro.10133 2.7.8.8 phosphatidylserinesynthase,yeast-specific Glycerolipid Metabolism [c] : 0.01 cdpdag_SC + ser-L <==> cmp + h + 0.01 ps_SC
R_PSSA_EC Chro.10133 2.7.8.8 Phosphatidylserinesyntase(Ecoli) Glycerolipid Metabolism [c] : 0.02 cdpdag_EC + ser-L <==> cmp + h + 0.02 ps_EC
R_LPS2 Chro.11000 3.1.1.3 lipase Glycerolipid Metabolism [c] : dag_hs + h2o --> Rtotal + h + mag_hs
R_LPS Chro.11000 3.1.1.3 lipase Glycerolipid Metabolism [c] : h2o + tag_hs --> Rtotal3 + dag_hs + h
R_PLA2_2 . 3.1.1.4 phospholipaseA2 Glycerolipid Metabolism [c] : h2o + pchol_hs --> Rtotal2 + h + lpchol_hs
R_ALKP Chro.70170 3.1.3.1 alkalinephosphatase Glycerolipid Metabolism [c] : dhap + h2o --> dha + pi
R_PIPLCn Chro.80452 or Chro.20310 or Chro.40288 or Chro.20201 or Chro.302613.1.4.3 p osphatidylinosit lphospholipaseC,nucleus Glycerolipid Metabolism [c] : h2o + pail_hs --> dag_hs + h + mi1p-D
R_GPDDA5 Chro.50344 or Chro.40291 3.1.4.46 Glycerophosphodiesterphosphodiesterase(Glycerophosphoinositol)Glycer ipid Metabolism [c] : g3pi + h2o --> glyc3p + h + inost
R_GPDDA4 Chro.50344 or Chro.40291 3.1.4.46 Glycerophosphodiesterphosphodiesterase(Glycerophosphoglycerol)Glycerolipid Metabolism [c] : g3pg + h2o --> glyc + glyc3p + h
R_GPDDA3 Chro.50344 or Chro.40291 3.1.4.46 Glycerophosphodiesterphosphodiesterase(Glycerophosphoserine)Glycerolipid Metabolism [c] : g3ps + h2o --> glyc3p + h + ser-L
R_GPDDA1 Chro.50344 or Chro.40291 3.1.4.46 Glycerophosphodiesterphosphodiesterase(Glycerophosphocholine)Glycerolipid Metabolism [c] : g3pc + h2o --> chol + glyc3p + h
R_GPDDA2 Chro.50344 or Chro.40291 3.1.4.46 Glycerophosphodiesterphosphodiesterase(Glycerophosphoethanolamine)Glycer lipid Metabolism [c] : g3pe + h2o --> etha + glyc3p + h
R_PSD_EC Chro.30247 4.1.1.65 Phosphatidylserinedecarboxylase(Ecoli) Glycerolipid Metabolism [c] : h + 0.02 ps_EC --> co2 + 0.02 pe_EC
R_PSD_HP Chro.30247 4.1.1.65 PhosphatidylserinedecarboxylaseHpspecific Glycerolipid Metabolism [c] : h + ps_HP --> co2 + pe_HP
R_PSD_SA Chro.30247 4.1.1.65 Phosphatidylserinedecarboxylase(Saureus) Glycerolipid Metabolism [c] : h + 0.02 ps_SA --> co2 + 0.02 pe_SA
R_G3PCT . 2.7.7.39 R_glycerol_3_phosphate_cytidylyltransferase Glycerophospholipid Metabolism [c] : 1.0 ctp + 1.0 glyc3p + 1.0 h --> 1.0 cdpglyc + 1.0 ppi
R_CDGPT_CT . 2.7.8.5 R_CDPdiacylglycerolsn_glycerol_3_phosphate_3_phosphatidyltransferaseGlyce ophospholipid Metabolism [c] : 1.0 cdpdag_CT + 1.0 glyc3p --> 1.0 cmp + 1.0 h + 1.0 pglyp_CT
R_PGPPH_CT . 3.1.3.27 R_Phosphatidylglycerophosphate_phosphohydrolase Glycerophospholipid Metabolism [c] : 1.0 h2o + 1.0 pglyp_CT --> 1.0 pgly_CT + 1.0 pi
R_PAP_CT . 3.1.3.4 R_phosphatidic_acid_phosphatase Glycerophospholipid Metabolism [c] : 1.0 12dag3p_CT + 1.0 h2o --> 1.0 12dgr_CT + 1.0 pi
R_41R2A1H12BOOX Chro.21000 1.4.3.4 _4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol:oxygenoxidoreductase(deaminating)(flavin-containing)Glycine, Serine, an  Threon e Metabolism[c] : h2o + nrpphr + o2 --> 34dhmald + h2o2 + nh4
R_5HOXINOXDA Chro.21000 1.4.3.4 _5-Hydroxytryptamine:oxygenoxidoreductase(deaminating)(flavin-containing)Glycine, Serine, a d Threonine Metabolism[c] : h2o + o2 + srtn --> 5hoxindact + h2o2 + nh4
R_3HXKYNOXDA Chro.21000 1.4.3.4 _3-Hydroxykynurenamine:oxygenoxidoreductase(deaminating)(flavin-containing)Glycine, Serine, and Threonine Metabolism[c] : 3hxkynam + o2 --> 48dhoxquin + h2o2 + nh4
R_5HXKYNOXDA Chro.21000 1.4.3.4 _5-Hydroxykynurenamine:oxygenoxidoreductase(deaminating)(flavin-containing)Glycine, Serine, and Threonine Metabolism[c] : 5hxkynam + o2 --> 46dhoxquin + h2o2 + nh4
R_41R1H2MAE12BOOXChro.21000 1.4.3.4 _4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]-1,2-benzenediol:oxygenoxidoreductase(deaminating)(flavin-containing)Glycine, Serine, an  Threonine Met bolism[c] : adrnl + h2o + o2 --> 34dhmald + h2o2 + mma
R_TRYPTAOX Chro.21000 1.4.3.4 Tryptamine:oxygenoxidoreductase(deaminating)(flavin-containing)Glyci e, Serine, and Threonine Metabolism[c] : h2o + o2 + trypta --> h2o2 + id3acald + nh4
R_13DAMPPOX Chro.80360 or Chro.30388 1.4.3.6 _1,3-Diaminopropane:oxygenoxidoreductase(deaminating)Glycine, Serine, and Threonine Metabolism[c] : 13dampp + h2o + o2 --> bamppald + h2o2 + nh4
R_HISTASE Chro.80360 or Chro.30388 1.4.3.6 Histaminase Glycine, Serine, and Threonine Metabolism[c] : h2o + hista + o2 --> h2o2 + im4act + nh4
R_42A12BOOX Chro.80360 or Chro.30388 1.4.3.6 _4-(2-Aminoethyl)-1,2-benzenediol:oxygenoxidoreductase(deaminating)(flavin-containing)Glycine, Serine, and Threoni e Metabolism[c] : dopa + h2o + o2 --> 34dhpac + h2o2 + nh4
R_PTRCOX1 Chro.80360 or Chro.30388 1.4.3.6 Putrescine:oxygenoxidoreductase(deaminating) Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + ptrc --> 4abutn + h2o2 + nh4
R_TYROXDAc Chro.80360 or Chro.30388 1.4.3.6 Tyramine:oxygenoxidoreductase(deaminating)(flavin-containing)(cytosol)Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + tym --> 4hoxpacd + h2o2 + nh4
R_PEAMNO Chro.80360 or Chro.30388 1.4.3.6 Phenethylamineoxidase Glycine, Serine, and Threonine Metabolism[c] : h2o + o2 + peamn --> h2o2 + nh4 + pacald
R_MAOX Chro.80360 or Chro.30388 1.4.3.6 Methylamineoxidase Glycine, Serine, and Threonine Metabolism[c] : h2o + mma + o2 --> fald + h2o2 + nh4
R_NMPTRCOX Chro.80360 or Chro.30388 1.4.3.6 N-Methylputrescine:oxygenoxidoreductase(deaminating) Glycine, Serine, and Threonine Metabolism[c] : nmptrc + o2 --> 1mpyr + h2o2 + nh4
R_HSK Chro.60426 2.7.1.39 homoserinekinase Glycine, Serine, and Threonine Metabolism[c] : atp + hom-L --> adp + h + phom
R_PSP_L Chro.70469 3.1.3.3 phosphoserinephosphatase(L-serine) Glycine, Serine, and Threonine Metabolism[c] : h2o + pser-L --> pi + ser-L
R_PSP_D Chro.70469 3.1.3.3 phosphoserinephosphatase(D-serine) Glycine, Serine, and Threonine Metabolism[c] : h2o + pser-D --> pi + ser-D
R_SERTRS Chro.80542 6.1.1.11 Seryl-tRNAsynthetase Glycine, Serine, and Threonine Metabolism[c] : atp + ser-L + trnaser --> amp + ppi + sertrna
R_GLYTRS Chro.80123 6.1.1.14 Glycyl-tRNAsynthetase Glycine, Serine, and Threonine Metabolism[c] : atp + gly + trnagly --> amp + glytrna + ppi
R_THRTRS Chro.70201 6.1.1.3 Threonyl-tRNAsynthetase Glycine, Serine, and Threonine Metabolism[c] : atp + thr-L + trnathr --> amp + ppi + thrtrna
R_ALCD2x Chro.80199 or Chro.80198 1.1.1.1 alcoholdehydrogenase(ethanol) Glycolysis/Gluconeogenesis [c] : etoh + nad <==> acald + h + nadh
R_GAPD Chro.60434 or Chro.10337 1.2.1.12 glyceraldehyde-3-phosphatedehydrogenase Glycolysis/Gluconeogenesis [c] : g3p + nad + pi <==> 13dpg + h + nadh
R_HEX1 Chro.60435 2.7.1.1 hexokinase Glycolysis/Gluconeogenesis [c] : atp + glc-D --> adp + h + g6p
R_PFKg Chro.20231 or Chro.30172 2.7.1.11 phosphofructokinase,glycosome Glycolysis/Gluconeogenesis [c] : atp + f6p --> adp + fdp + h
R_GLUK . 2.7.1.2 Glucokinase Glycolysis/Gluconeogenesis [c] : atp + glc-D --> adp + g6p-B + h
R_PYK Chro.10234 2.7.1.40 pyruvatekinase Glycolysis/Gluconeogenesis [c] : adp + h + pep --> atp + pyr
R_PGKg Chro.70113 2.7.2.3 phosphoglyceratekinase Glycolysis/Gluconeogenesis [c] : 3pg + atp <==> 13dpg + adp
R_ACYP Chro.70488 3.6.1.7 acylphosphatase Glycolysis/Gluconeogenesis [c] : 13dpg + h2o --> 3pg + h + pi
R_PYRDC Chro.70351 4.1.1.1 pyruvatedecarboxylase Glycolysis/Gluconeogenesis [c] : h + pyr --> acald + co2
R_FBA Chro.10335 4.1.2.13 fructose-bisphosphatealdolase Glycolysis/Gluconeogenesis [c] : fdp <==> dhap + g3p
R_ENO Chro.50184 4.2.1.11 enolase Glycolysis/Gluconeogenesis [c] : 2pg <==> h2o + pep
R_PGI Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Glycolysis/Gluconeogenesis [c] : g6p <==> f6p
R_PGM Chro.10196 or Chro.70471 5.4.2.1 phosphoglyceratemutase Glycolysis/Gluconeogenesis [c] : 2pg <==> 3pg
R_PGMT Chro.20343 5.4.2.2 phosphoglucomutase Glycolysis/Gluconeogenesis [c] : g1p <==> g6p
R_ACSm Chro.10418 6.2.1.1 acetyl-CoAsynthetase Glycolysis/Gluconeogenesis [c] : ac + atp + coa --> accoa + amp + ppi
R_RBPC Chro.20166 4.1.1.39 ribulose-bisphosphatecarboxylase Glyoxylate and dicarboxylate Metabolism [c] : co2 + h2o + rb15bp --> 2 3pg + 2 h
R_HISTRS Chro.80461 6.1.1.21 Histidyl-tRNAsynthetase Histidine Metabolism [c] : atp + his-L + trnahis --> amp + histrna + ppi
R_PIN3K_SC Chro.80217 or Chro.60213 2.7.1.137 _1-phosphatidylinositol3-kinase,yeast-specific Inositol Phosphate Metabolism [c] : atp + 0.01 ptd1ino_SC --> adp + h + 0.01 ptd3ino_SC
R_PIK3 Chro.80217 or Chro.60213 2.7.1.137 phosphatidylinositol3-kinase Inositol Phosphate Metabolism [c] : atp + pail_hs --> adp + h + pail3p_hs
R_PIN4K_SC Chro.60392 or Chro.80518 2.7.1.67 phosphatidylinositol4-kinase,yeast-specific Inositol Phosphate Metabolism [c] : atp + 0.01 ptd1ino_SC --> adp + h + 0.01 ptd4ino_SC
R_PI4P5K_SC Chro.20207 2.7.1.68 phosphatidylinositol-4-phosphate5-kinase,yeast-specfic Inositol Phosphate Metabolism [c] : atp + 0.01 ptd4ino_SC --> adp + h + 0.01 ptd145bp_SC
R_PI4P5K Chro.20207 2.7.1.68 phosphatidylinositol4-phosphate5-kinase Inositol Phosphate Metabolism [c] : atp + pail4p_hs --> adp + h + pail45p_hs
R_MI1345PP Chro.50026 3.1.3.56 inositol-1,3,4,5-trisphosphate5-phosphatase Inositol Phosphate Metabolism [c] : h2o + mi1345p --> mi134p + pi
R_MI145PP Chro.50026 3.1.3.56 inositol-1,4,5-trisphosphate5-phosphatase Inositol Phosphate Metabolism [c] : h2o + mi145p --> mi14p + pi
R_PI45PLC Chro.40288 3.1.4.11 phosphatidylinositol4,5-bisphosphatephospholipaseC Inositol Phosphate Metabolism [c] : h2o + pail45p_hs --> dag_hs + h + mi145p
R_PI45BPP_SC Chro.40288 3.1.4.11 _1-phosphatidylinositol-4,5-bisphosphatephosphodiesterase,yeast-specificInositol Phosphate Metabolism [c] : h2o + 0.01 ptd145bp_SC --> 0.01 12dgr_SC + h + mi145p
R_PIPLC Chro.80452 or Chro.20310 or Chro.40288 or Chro.20201 or Chro.302613.1.4.3 p osphatidylinosit lphospholipaseC Inositol Phosphate Metabolism [c] : h2o + pail_hs --> dag_hs + h + mi1p-D
R_AASAD3 Chro.40330 1.2.1.31 L-aminoadipate-semialdehydedehydrogenase(NADH) Lysine Biosynthesis [c] : L2aadp6sa + h2o + nad --> L2aadp + 2 h + nadh
R_AASAD2 Chro.40330 1.2.1.31 L-aminoadipate-semialdehydedehydrogenase(NADH) Lysine Biosynthesis [c] : L2aadp + atp + h + nadh --> L2aadp6sa + amp + nad + ppi
R_AASAD1 Chro.40330 1.2.1.31 L-aminoadipate-semialdehydedehydrogenase(NADPH) Lysine Biosynthesis [c] : L2aadp + atp + h + nadph --> L2aadp6sa + amp + nadp + ppi
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R_LYSTRS Chro.40267 6.1.1.6 Lysyl-tRNAsynthetase Lysine Biosynthesis [c] : atp + lys-L + trnalys --> amp + lystrna + ppi
R_LYSMTF2 Chro.40051 2.1.1.43 histone-lysineN-methyltransferase,nuclear Lysine Degradation [c] : Nmelys + amet --> Ndmelys + ahcys
R_LYSMTF3 Chro.40051 2.1.1.43 histone-lysineN-methyltransferase,nuclear Lysine Degradation [c] : Ndmelys + amet --> Ntmelys + ahcys
R_LYSMTF1 Chro.40051 2.1.1.43 histone-lysineN-methyltransferase,nuclear Lysine Degradation [c] : amet + peplys --> Nmelys + ahcys
R_PRDX Chro.40093 or Chro.80075 or Chro.300631.11.1.7 Peroxidase(multiplesubstrates) Methane Metabolism [c] : h2o2 + meoh --> fald + 2 h2o
R_GHMT3 Chro.80302 or Chro.80306 2.1.2.1 glycinehydroxymethyltransferase Methane Metabolism [c] : 3htmelys + h --> 4tmeabut + gly
R_GHMT2r Chro.80302 or Chro.80306 2.1.2.1 glycinehydroxymethyltransferase,reversible Methane Metabolism [c] : ser-L + thf <==> gly + h2o + mlthf
R_DNAMT Chro.50169 2.1.1.37 DNA(cytosine-5-)-methyltransferase,nucleus Methionine Metabolism [c] : amet + dna --> ahcys + dna5mtc + h
R_DNAMTSE Chro.50169 2.1.1.37 DNA(cytosine-5-)-methyltransferase,nucleus Methionine Metabolism [c] : dna + seasmet --> dna5mtc + h + seahcys
R_METAT Chro.70301 2.5.1.6 methionineadenosyltransferase Methionine Metabolism [c] : atp + h2o + met-L --> amet + pi + ppi
R_AHC Chro.30017 3.3.1.1 adenosylhomocysteinase Methionine Metabolism [c] : ahcys + h2o <==> adn + hcys-L
R_METTRS Chro.80398 6.1.1.10 Methionyl-tRNAsynthetase Methionine Metabolism [c] : atp + met-L + trnamet --> amp + mettrna + ppi
R_G3POA_CT . . R_glycerol_3_phosphate_O_acyltransferase Miscellaneous [c] : 1.0 glyc3p + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 pmtcoa + 0.1334 fa12coa + 0.1255 hdcoa + 0.0479 strcoaiso + 0.0137 strcoa --> 1.0 1ag3p_CT + 1.0 coa
R_LYSLG_CT . . R_lysylphosphatidylglycerol_synthesis Miscellaneous [c] : 1.0 atp + 1.0 lys-L + 1.0 pgly_CT --> 1.0 amp + 1.0 h + 1.0 lysylpgly_CT + 1.0 ppi
R_UGT_CT . . R_UDP_glucosyltransferase__diglucosyl_ Miscellaneous [c] : 1.0 12dgr_CT + 2.0 udpg --> 1.0 d12dg_CT + 2.0 h + 2.0 udp
R_UGT1_CT . . R_UDP_glucosyltransferase__monoglucosyl_ Miscellaneous [c] : 1.0 12dgr_CT + 1.0 udpg --> 1.0 h + 1.0 m12dg_CT + 1.0 udp
R_UGT2_CT . . R_UDP_glucosyltransferase__triglucosyl_ Miscellaneous [c] : 1.0 12dgr_CT + 3.0 udpg --> 3.0 h + 1.0 t12dg_CT + 3.0 udp
R_LIPO1S24_CT . . R_lipoteichoic_acid_synthesis__n24___linked__glucose_substitutedMiscellaneous [c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 udpg --> 24.0 cmp + 48.0 h + 1.0 lipo1_24_CT + 24.0 udp
R_LIPO2S24_CT . . R_lipoteichoic_acid_synthesis__n24___linked__N_acetylglucosamine_substitutedMiscellaneous [c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 uacgam --> 24.0 cmp + 48.0 h + 1.0 lipo2_24_CT + 24.0 udp
R_LIPO3S24_CT . . R_lipoteichoic_acid_synthesis__n24___unliked__D_alanine_substitutedMiscellaneous [c] : 24.0 ala-D + 24.0 atp + 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 h2o --> 24.0 amp + 24.0 cmp + 48.0 h + 1.0 lipo3_24_CT + 24.0 ppi
R_LIPO4S24_CT . . R_lipoteichoic_acid_synthesis__n24___linked__unsubstitutedMiscellaneous [c] : 24.0 cdpglyc + 1.0 d12dg_CT --> 24.0 cmp + 24.0 h + 1.0 lipo4_24_CT
R_TECA1S45 . . R_glycerol_teichoic_acid__n45___unlinked__unsubstitutedMiscellaneous [c] : 45.0 cdpglyc + 1.0 uacgam + 1.0 uacmam --> 45.0 cmp + 1.0 gtca1_45_CT + 46.0 h + 1.0 udp + 1.0 ump
R_TECA2S45 . . R_glycerol_teichoic_acid__n45___unlinked__D_ala_substitutedMisc llaneous [c] : 45.0 ala-D + 45.0 atp + 45.0 cdpglyc + 45.0 h2o + 1.0 uacgam + 1.0 uacmam --> 45.0 amp + 45.0 cmp + 1.0 gtca2_45_CT + 91.0 h + 45.0 ppi + 1.0 udp + 1.0 ump
R_TECA3S45 . . R_glycerol_teichoic_acid__n45___unlinked__glucose_substitutedMiscellaneous [c] : 45.0 cdpglyc + 1.0 h2o + 1.0 uacgam + 1.0 uacmam + 45.0 udpg --> 45.0 cmp + 1.0 gtca3_45_CT + 91.0 h + 46.0 udp + 1.0 ump
R_TECA4S_CT . . R_minor_teichoic_acid_synthesis__n30_ Miscellaneous [c] : 30.0 h2o + 30.0 uacgala + 30.0 udpg --> 60.0 h + 1.0 tcam_CT + 30.0 udp + 30.0 ump
R_TEICH45 . . R_teichuronic_acid__n45___unlinked__GalNAc_GlcA_repeatedMiscellaneous [c] : 45.0 uacgala + 45.0 udpglcur <==> 45.0 h + 1.0 teich_45_CT + 45.0 udp + 45.0 ump
R_UAGPT3 . . R_UDP_N_acetylglucosamine_N_acetylmuramyl__pentapeptide_pyrophosphoryl_undecaprenol_N_acetylglucosamine_transferaseMiscellaneous [c] : 1.0 uacgam + 1.0 uagmda --> 1.0 h + 1.0 uaagmda + 1.0 udp
R_PPTGS_CT . . R_Peptidoglycan_subunit_synthesis Miscellaneous [c] : 1.0 uaagmda --> 1.0 h + 1.0 peptido_CT + 1.0 udcpdp
R_FRTT . . R_farnesyltranstransferase Miscellaneous [c] : 1.0 frdp + 1.0 ipdp --> 1.0 ggdp + 1.0 ppi
R_GGTT . . R_geranylgeranyltranstransferase Miscellaneous [c] : 1.0 ggdp + 1.0 ipdp --> 1.0 pendp + 1.0 ppi
R_PPTT . . R_trans_pentaprenyltranstransferase Miscellaneous [c] : 1.0 ipdp + 1.0 pendp --> 1.0 hexdp + 1.0 ppi
R_HEXTT . . R_trans_hexaprenyltranstransferase Miscellaneous [c] : 1.0 hexdp + 1.0 ipdp --> 1.0 hepdp + 1.0 ppi
R_ICHORS . . R_isochorismate_synthase Miscellaneous [c] : 1.0 chor <==> 1.0 ichor
R_2S6HCCi . . R_2_succinyl_6_hydroxy_2_4_cyclohexadiene_1_carboxylate_synthaseMiscella eous [c] : 1.0 akg + 1.0 h + 1.0 ichor --> 1.0 2shchc + 1.0 co2 + 1.0 pyr
R_SUCBZS . . R_O_succinylbenzoate_CoA_synthase Miscellaneous [c] : 1.0 2shchc --> 1.0 h2o + 1.0 sucbz
R_SUCBZL . . R_o_succinylbenzoate_CoA_ligase Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 sucbz --> 1.0 amp + 1.0 ppi + 1.0 sbzcoa
R_NPHS . . R_naphthoate_synthase Miscellaneous [c] : 1.0 sbzcoa --> 1.0 coa + 1.0 dhna
R_DHNAOT7 . . R_1_4_dihydroxy_2_naphthoate_octaprenyltransferase Miscellaneous [c] : 1.0 dhna + 1.0 hepdp + 1.0 nad --> 1.0 2dmmq7 + 1.0 co2 + 1.0 nadh + 1.0 ppi
R_AMMQT7 . . R_S_adenosylmethione2_demthylmenaquinone_methyltransferase__menaquinone_7_Mi c llaneous [c] : 1.0 2dmmq7 + 1.0 amet + 1.0 nadph --> 1.0 ahcys + 1.0 mql7 + 1.0 nadp
R_H2CO3D2 . . carboxylicaciddissociation Miscellaneous [c] : h + hco3 <==> h2co3
R_IPDPS 1.17.1.2 _1-hydroxy-2-methyl-2-(E)-butenyl4-diphosphatereductase(ipdp)Miscellaneous [c] : h + h2mb4p + nadh --> h2o + ipdp + nad
R_MECDPDH . 1.17.4.3 _2C-methyl-D-erythritol2,4cyclodiphosphatedehydratase Miscellaneous [c] : 2mecdp + h --> h2mb4p + h2o
R_AGPATr_CT Chro.80165 2.3.1.51 R_1_acylglycerol_3_phosphate_O_acyltransferase Miscellaneous [c] : 1.0 1ag3p_CT + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 pmtcoa + 0.1334 fa12coa + 0.1255 hdcoa + 0.0479 strcoaiso + 0.0137 strcoa --> 1.0 12dag3p_CT  + 1.0 coa
R_DAGK_CT Chro.40493 2.7.1.107 R_diacylglycerol_kinase Miscellaneous [c] : 1.0 12dgr_CT + 1.0 atp --> 1.0 12dag3p_CT + 1.0 adp + 1.0 h
R_PHCYT_CT Chro.70332 2.7.7.41 R_phosphatidate_cytidylyltransferase Miscellaneous [c] : 1.0 12dag3p_CT + 1.0 ctp + 1.0 h --> 1.0 cdpdag_CT + 1.0 ppi
R_CLPNS2_CT . 2.7.8.- R_cardiolipin_synthase Miscellaneous [c] : 2.0 pgly_CT --> 1.0 cdlp_CT + 1.0 glyc
R_CDPDSP_CT Chro.10133 2.7.8.8 R_CDPdiacylglycerol_serine_O_phosphatidyltransferase Miscellaneous [c] : 1.0 cdpdag_CT + 1.0 ser-L --> 1.0 cmp + 1.0 h + 1.0 ps_CT
R_PSDC_CT Chro.30247 4.1.1.65 R_phosphatidylserine_decarboxylase Miscellaneous [c] : 1.0 ps_CT --> 1.0 co2 + 1.0 psetha_CT
R_FACOAL100 Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C100_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 dca <==> 1.0 amp + 1.0 dcacoa + 1.0 ppi
R_FACOAL130 Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C130_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 trdca <==> 1.0 amp + 1.0 trdacoa + 1.0 ppi
R_FACOAL140_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C140_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa1 <==> 1.0 amp + 1.0 fa1coa + 1.0 ppi
R_FACOAL150_anteiso_Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__anteiso_C150_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa4 <==> 1.0 amp + 1.0 fa4coa + 1.0 ppi
R_FACOAL150_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C150_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa3 <==> 1.0 amp + 1.0 fa3coa + 1.0 ppi
R_FACOAL160_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C160_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa6 <==> 1.0 amp + 1.0 fa6coa + 1.0 ppi
R_FACOAL161_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C161_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa5 <==> 1.0 amp + 1.0 fa5coa + 1.0 ppi
R_FACOAL170_anteiso_Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__anteiso_C170_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa12 <==> 1.0 amp + 1.0 fa12coa + 1.0 ppi
R_FACOAL170_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C170_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa11 <==> 1.0 amp + 1.0 fa11coa + 1.0 ppi
R_FACOAL171_anteiso_Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__anteiso_C171_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa10 <==> 1.0 amp + 1.0 fa10coa + 1.0 ppi
R_FACOAL171_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C171_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 fa9 <==> 1.0 amp + 1.0 fa9coa + 1.0 ppi
R_FACOAL180_ISO_ Chro.50052 or Chro.30084 6.2.1.3 R_fatty_acid__CoA_ligase__Iso_C180_ Miscellaneous [c] : 1.0 atp + 1.0 coa + 1.0 ocdcaiso <==> 1.0 amp + 1.0 ppi + 1.0 strcoaiso
R_THD2 Chro.80274 1.6.1.1 NAD(P)transhydrogenase NAD Metabolism 2 h[e] + nadh[c] + nadp[c] --> 2 h[c] + nad[c] + nadph[c]
R_NADTRHD Chro.10120 1.6.1.2 NADtranshydrogenase NAD Metabolism [c] : nad + nadph --> nadh + nadp
R_NADK Chro.80231 2.7.1.23 NADkinase NAD Metabolism [c] : atp + nad --> adp + h + nadp
R_UDPDOLPT_U Chro.50118 2.4.1.117 UDPglucose:dolichyl-phosphatebeta-D-glucosyltransferase(uterus)N-Glycan Biosynthesis [c] : 0.1 dolp_U + udpg --> 0.1 dolglcp_U + udp
R_UDPDOLPT_L Chro.50118 2.4.1.117 UDPglucose:dolichyl-phosphatebeta-D-glucosyltransferase(liver)N-Glycan Biosynthesis [c] : 0.1 dolp_L + udpg --> 0.1 dolglcp_L + udp
R_DOLASNT_Uer Chro.20179 or Chro.60585 2.4.1.119 Dolichyl-diphosphooligosaccharide:protein-L-asparagineoligopolysaccharidotransferase(uterus)N-Glycan Biosynthesis [c] : Asn-X_DASH_Ser_FSLASH_Thr + 0.1 g3m8mpdol_U --> 0.1 doldp_U + g3m8masn + h
R_DOLASNT_Ler Chro.20179 or Chro.60585 2.4.1.119 Dolichyl-diphosphooligosaccharide:protein-L-asparagineoligopolysaccharidotransferase(liver)N-Glycan Biosynthesis [c] : Asn-X_DASH_Ser_FSLASH_Thr + 0.1 g3m8mpdol_L --> 0.1 doldp_L + g3m8masn + h
R_DOLPMT_L Chro.50175 2.4.1.83 Dolichyl-phosphateD-mannosyltransferase(liver) N-Glycan Biosynthesis [c] : 0.1 dolp_L + gdpmann --> 0.1 dolmanp_L + gdp
R_DOLPMT_U Chro.50175 2.4.1.83 Dolichyl-phosphateD-mannosyltransferase(uterus) N-Glycan Biosynthesis [c] : 0.1 dolp_U + gdpmann --> 0.1 dolmanp_U + gdp
R_DOLPMTcer Chro.50175 2.4.1.83 Dolichyl-phosphateD-mannosyltransferase N-Glycan Biosynthesis dolp[c] + gdpmann[c] --> dolmanp[r] + gdp[c]
R_DOLK Chro.20170 2.7.1.108 Dolicholkinase N-Glycan Biosynthesis [c] : ctp + dolichol --> cdp + dolp + h
R_DOLK_U Chro.20170 2.7.1.108 Dolicholkinase,human(uterus) N-Glycan Biosynthesis [c] : ctp + 0.1 dolichol_U --> cdp + 0.1 dolp_U + h
R_DOLK_L Chro.20170 2.7.1.108 Dolicholkinase,human(liver) N-Glycan Biosynthesis [c] : ctp + 0.1 dolichol_L --> cdp + 0.1 dolp_L + h
R_GLCNACPT_L Chro.50156 2.7.8.15 UDP-GlcNAc:dolichol-phosphateGlcNAcphosphotransferase(liver)N-Glycan Biosynthesis [c] : 0.1 dolp_L + uacgam --> 0.1 naglc2p_L + ump
R_GLCNACPT_U Chro.50156 2.7.8.15 UDP-GlcNAc:dolichol-phosphateGlcNAcphosphotransferase(uterus)N-Glycan Biosynthesis [c] : 0.1 dolp_U + uacgam --> 0.1 naglc2p_U + ump
R_HCO3E Chro.40064 4.2.1.1 HCO3equilibrationreaction Nitrogen Metabolism [c] : co2 + h2o <==> h + hco3
R_H2CO3D Chro.40064 4.2.1.1 carboxylicaciddissociation Nitrogen Metabolism [c] : co2 + h2o <==> h2co3
R_ASNS2 Chro.50501 6.3.1.1 asparaginesynthetase Nitrogen Metabolism [c] : asp-L + atp + nh4 --> amp + asn-L + h + ppi
R_GLNS Chro.60524 6.3.1.2 glutaminesynthetase Nitrogen Metabolism [c] : atp + glu-L + nh4 --> adp + gln-L + h + pi
R_ASNS1 Chro.30020 6.3.5.4 asparaginesynthase(glutamine-hydrolysing) Nitrogen Metabolism [c] : asp-L + atp + gln-L + h2o --> amp + asn-L + glu-L + h + ppi
R_G1PTT Chro.80452 2.7.7.24 glucose-1-phosphatethymidylyltransferase Nucleotide Sugar Metabolism [c] : dttp + g1p + h --> dtdpglu + ppi
R_TDPGDH Chro.20206 4.2.1.46 dTDPglucose4,6-dehydratase Nucleotide Sugar Metabolism [c] : dtdpglu --> dtdp4d6dg + h2o
R_GALNT Chro.60231 or Chro.50322 or Chro.701572.4.1.4 GalNActransferase,Golgiapparatus O-Glycan Biosynthesis [c] : Ser_FSLASH_Thr + udpacgal --> Tn_antigen + h + udp
R_NADH10 Chro.70218 1.6.5.3 NADHdehydrogenase(menaquinone-8&0protons) Oxidative Phosphorylation [c] : h + mqn8 + nadh --> mql8 + nad
R_ECHH_1_PERIOD_0Chro.70218 1.6.5.3 EchHydrogenase Oxidative Phosphorylation 2 fdred[c] + 3 h[c] <==> 2 fdox[c] + h[e] + h2[c]
R_NADH5 Chro.70218 1.6.5.3 NADHdehydrogenase(ubiquinone-8) Oxidative Phosphorylation [c] : h + nadh + q8 --> nad + q8h2
R_NADH7 Chro.70218 1.6.5.3 NADHdehydrogenase(menaquinone-8&2protons) Oxidative Phosphorylation 3 h[c] + mqn8[c] + nadh[c] --> 2 h[e] + mql8[c] + nad[c]
R_NADH6 Chro.70218 1.6.5.3 NADHdehydrogenase(ubiquinone-8&3.5protons) Oxidative Phosphorylation 4.5 h[c] + nadh[c] + q8[c] --> 3.5 h[e] + nad[c] + q8h2[c]
R_NADH9 Chro.70218 1.6.5.3 NADHdehydrogenase(demethylmenaquinone-8&0protons)Oxidative Phosphorylation [c] : 2dmmq8 + h + nadh --> 2dmmql8 + nad
R_NADH8 Chro.70218 1.6.5.3 NADHdehydrogenase(demethylmenaquinone-8&2.8protons)Oxidative Phosphorylation 2dmmq8[c] + 3.8 h[c] + nadh[c] --> 2dmmql8[c] + 2.8 h[e] + nad[c]
R_NADH2_DASH_u6cmChro.70218 1.6.99.3 NADHdehydrogenase,cytosolic/mitochondrial Oxidative Phosphorylation h[c] + nadh[c] + q6[c] --> nad[c] + q6h2[c]
R_CYOO_HP Chro.70168 1.9.3.1 cytochromec553oxidase,Hpylori Oxidative Phosphorylation 4 focytcc553[c] + 5.98 h[c] + o2[c] --> 4 ficytcc553[c] + 2 h[e] + 1.99 h2o[c] + 0.005 o2s[c]
R_PPA_1 Chro.40159 3.6.1.1 inorganicdiphosphatase(oneprotontranslocation) Oxidative Phosphorylation h2o[c] + ppi[c] --> h[e] + 2 pi[c]
R_PPA2 Chro.40159 3.6.1.1 inorganictriphosphatase Oxidative Phosphorylation [c] : h2o + pppi --> h + pi + ppi
R_PPA Chro.40159 3.6.1.1 inorganicdiphosphatase Oxidative Phosphorylation [c] : h2o + ppi --> h + 2 pi
R_ATPS4r Chro.60082 and Chro.20424 and Chro.80551 and Chro.70559 and Chro.50340 and Chro.50039 and Chro.10063 and Chro.10062 and Chro.50302 and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149 and Chro.201483.6.3.14 ATPsynthase(fourprotonsforoneATP) Oxidative Phosp orylation adp[c] + 4 h[e] + pi[c] <==> atp[c] + 3 h[c] + h2o[c]
R_ATPasel Chro.60082 and Chro.20424 and Chro.80551 and Chro.70559 and Chro.50340 and Chro.50039 and Chro.10063 and Chro.10062 and Chro.50302 and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149 and Chro.201483.6.3.14 V-typeATPase,H+transporting,lysosomal Oxidative Phosp orylation atp[c] + 3 h[c] + h2o[c] --> adp[c] + 4 h[l] + pi[c]
R_ATPS Chro.20424 and Chro.70559 and Chro.50302 and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149 and Chro.201483.6.3.6 ATPase,cytosolic Oxidative Phosp orylation atp[c] + h2o[c] --> adp[c] + h[e] + pi[c]
R_CAATPS Chro.20424 and Chro.70559 and Chro.50302 and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149 and Chro.201483.6.3.6 CaATPase Oxidative Phosp orylation atp[c] + 2 ca2[c] + h2o[c] --> adp[c] + 2 ca2[e] + h[e] + pi[c]
R_ATPS1 Chro.20424 and Chro.70559 and Chro.50302 and Chro.80195 and Chro.80048 and Chro.40070 and Chro.20149 and Chro.201483.6.3.6 H+-exp rtingATP se Oxidative Phosp orylation atp[c] + h[c] + h2o[c] --> adp[c] + 2 h[e] + pi[c]
R_DPCOAK Chro.20045 2.7.1.24 dephospho-CoAkinase Pantothenate-Vit B5 and CoA biosynthesis [c] : atp + dpcoa --> adp + coa + h
R_PNTK Chro.70552 or Chro.80038 2.7.1.33 pantothenatekinase Pantothenate-Vit B5 and CoA biosynthesis [c] : atp + pnto-R --> 4ppan + adp + h
R_PFK_2 Chro.20231 2.7.1.11 Phosphofructokinase Pentose Phosphate Pathway [c] : atp + tag6p-D --> adp + h + tagdp-D
R_PFK_3 Chro.20231 2.7.1.11 phosphofructokinase(s7p) Pentose Phosphate Pathway [c] : atp + s7p --> adp + h + s17bp
R_PFK Chro.20231 2.7.1.11 phosphofructokinase Pentose Phosphate Pathway [c] : atp + f6p --> adp + fdp + h
R_G6PI2 Chro.20336 5.3.1.9 Glucose-6-phosphateisomerase Pentose Phosphate Pathway [c] : g6p-B <==> f6p-B
R_G6PI Chro.20336 5.3.1.9 Glucose-6-phosphateisomerase Pentose Phosphate Pathway [c] : g6p <==> g6p-B
R_SHKK Chro.30373 2.7.1.71 shikimatekinase Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : atp + skm --> adp + h + skm5p
R_DHQD Chro.80609 4.2.1.10 _3-dehydroquinatedehydratase Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : 3dhq <==> 3dhsk + h2o
R_TRPS3 Chro.50503 4.2.1.20 tryptophansynthase(indoleglycerolphosphate) Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : 3ig3p --> g3p + indole
R_TRPS2 Chro.50503 4.2.1.20 tryptophansynthase(indole) Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : indole + ser-L --> h2o + trp-L
R_TRPS1 Chro.50503 4.2.1.20 tryptophansynthase(indoleglycerolphosphate) Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : 3ig3p + ser-L --> g3p + h2o + trp-L
R_TYRTRS Chro.40444 or Chro.60344 6.1.1.1 tyrosyl-tRNAsynthetase Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : atp + trnatyr + tyr-L --> amp + ppi + tyrtrna
R_PHETRS Chro.30378 or Chro.80385 6.1.1.20 Phenylalanyl-tRNAsynthetase Phenylalanine, Tyrosine and Tryptophan Biosynthesis[c] : atp + phe-L + trnaphe --> amp + phetrna + ppi
R_UPP3S . 4.2.1.75 uroporphyrinogen-IIIsynthase Porphyrin and chlorophyll metabolism [c] : hmbil --> h2o + uppg3
R_GLUTRS_LPAREN_Gln_RPAREN_Chro.60505 or Chro.80098 or Chro.102446.1.1.17 Glutamyl-tRNAsynthetase(Gln) Porphyrin and chlorophyll metabolism [c] : atp + glu-L + trnagln --> amp + glutrna_LPAREN_gln_RPAREN_ + ppi
R_ACOAD3 Chro.31000 or Chro.41000 1.3.99.3 acyl-CoAdehydrogenase(octanoyl-CoA) Propanoate Metabolism [c] : nad + occoa <==> h + nadh + oc2coa
R_ACOAD5 Chro.31000 or Chro.41000 1.3.99.3 acyl-CoAdehydrogenase(dodecanoyl-CoA) Propanoate Metabolism [c] : ddcacoa + nad <==> dd2coa + h + nadh
R_ACOAD4 Chro.31000 or Chro.41000 1.3.99.3 acyl-CoAdehydrogenase(decanoyl-CoA) Propanoate Metabolism [c] : dcacoa + nad <==> dc2coa + h + nadh
R_ACOAD7 Chro.31000 or Chro.41000 1.3.99.3 acyl-CoAdehydrogenase(hexadecanoyl-CoA) Propanoate Metabolism [c] : nad + pmtcoa --> h + hdd2coa + nadh
R_ACOAD6 Chro.31000 or Chro.41000 1.3.99.3 acyl-CoAdehydrogenase(tetradecanoyl-CoA) Propanoate Metabolism [c] : nad + tdcoa <==> h + nadh + td2coa
R_ACOAD2 Chro.31000 or Chro.41000 1.3.99.3 acyl-CoAdehydrogenase(hexanoyl-CoA) Propanoate Metabolism [c] : h + hx2coa + nadh <==> hxcoa + nad
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R_ACCOACr Chro.80425 6.4.1.2 acetyl-CoAcarboxylase,reversiblereaction Propanoate Metabolism [c] : accoa + atp + hco3 <==> adp + h + malcoa + pi
R_IMPD Chro.60012 1.1.1.205 IMPdehydrogenase Purine Metabolism [c] : h2o + imp + nad --> h + nadh + xmp
R_RNDR2n Chro.60090 or Chro.60091 1.17.4.1 ribonucleoside-diphosphatereductase(GDP),nuclear Purine Metabolism [c] : gdp + trdrd --> dgdp + h2o + trdox
R_RNDR4n Chro.60090 or Chro.60091 1.17.4.1 ribonucleoside-diphosphatereductase(UDP),nuclear Purine Metabolism [c] : trdrd + udp --> dudp + h2o + trdox
R_ADNK2 Chro.20322 2.7.1.20 adenosinekinase Purine Metabolism [c] : adn + gtp --> adp + gmp + h
R_ADNK1 Chro.20322 2.7.1.20 adenosinekinase Purine Metabolism [c] : adn + atp --> adp + amp + h
R_ADK2 Chro.50037 2.7.4.3 adenylatekinase(Inorganictriphosphate) Purine Metabolism [c] : amp + pppi <==> adp + ppi
R_NDPK10 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:dIDP) Purine Metabolism [c] : atp + didp <==> adp + ditp
R_NDPK9 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:IDP) Purine Metabolism [c] : atp + idp <==> adp + itp
R_NDPK8 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:dADP) Purine Metabolism [c] : atp + dadp <==> adp + datp
R_NDPK7 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:dCDP) Purine Metabolism [c] : atp + dcdp <==> adp + dctp
R_NDPK6 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:dUDP) Purine Metabolism [c] : atp + dudp <==> adp + dutp
R_NDPK5 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:dGDP) Purine Metabolism [c] : atp + dgdp <==> adp + dgtp
R_NDPK4 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:dTDP) Purine Metabolism [c] : atp + dtdp <==> adp + dttp
R_NDPK3 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:CDP) Purine Metabolism [c] : atp + cdp <==> adp + ctp
R_NDPK2 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:UDP) Purine Metabolism [c] : atp + udp <==> adp + utp
R_NDPK1 Chro.40275 or Chro.50237 or Chro.402192.7.4.6 nucleoside-diphosphatekinase(ATP:GDP) Purine Metabolism [c] : atp + gdp <==> adp + gtp
R_DGK1 Chro.70250 2.7.4.8 deoxyguanylatekinase(dGMP:ATP) Purine Metabolism [c] : atp + dgmp <==> adp + dgdp
R_GK1 Chro.70250 2.7.4.8 guanylatekinase(GMP:ATP) Purine Metabolism [c] : atp + gmp <==> adp + gdp
R_NTD11 Chro.50026 3.1.3.5 _5'-nucleotidase(IMP) Purine Metabolism [c] : h2o + imp --> ins + pi
R_NTD10 Chro.50026 3.1.3.5 _5'-nucleotidase(XMP) Purine Metabolism [c] : h2o + xmp --> pi + xtsn
R_NTD12 Chro.50026 3.1.3.5 _5'-nucleotidase(dIMP) Purine Metabolism [c] : dimp + h2o --> din + pi
R_NTD9 Chro.50026 3.1.3.5 _5'-nucleotidase(GMP) Purine Metabolism [c] : gmp + h2o --> gsn + pi
R_NTD8 Chro.50026 3.1.3.5 _5'-nucleotidase(dGMP) Purine Metabolism [c] : dgmp + h2o --> dgsn + pi
R_NTD1 Chro.50026 3.1.3.5 _5'-nucleotidase(dUMP) Purine Metabolism [c] : dump + h2o --> duri + pi
R_NTD3 Chro.50026 3.1.3.5 _5'-nucleotidase(dCMP) Purine Metabolism [c] : dcmp + h2o --> dcyt + pi
R_NTD2 Chro.50026 3.1.3.5 _5'-nucleotidase(UMP) Purine Metabolism [c] : h2o + ump --> pi + uri
R_NTD5 Chro.50026 3.1.3.5 _5'-nucleotidase(dTMP) Purine Metabolism [c] : dtmp + h2o --> pi + thymd
R_NTD4 Chro.50026 3.1.3.5 _5'-nucleotidase(CMP) Purine Metabolism [c] : cmp + h2o --> cytd + pi
R_NTD7 Chro.50026 3.1.3.5 _5'-nucleotidase(AMP) Purine Metabolism [c] : amp + h2o --> adn + pi
R_NTD6 Chro.50026 3.1.3.5 _5'-nucleotidase(dAMP) Purine Metabolism [c] : damp + h2o --> dad-2 + pi
R_NT5C Chro.50026 3.1.3.5 _5'-nucleotidase Purine Metabolism [c] : h2o + nicrnt --> nicrns + pi
R_PDE1 Chro.30269 or Chro.60462 3.1.4.17 _3',5'-cyclic-nucleotidephosphodiesterase Purine Metabolism [c] : camp + h2o --> amp + h
R_PDE2 Chro.30269 or Chro.60462 3.1.4.17 _3',5'-cyclic-nucleotidephosphodiesterase Purine Metabolism [c] : 35cdamp + h2o --> damp + h
R_PDE3 Chro.30269 or Chro.60462 3.1.4.17 _3',5'-cyclic-nucleotidephosphodiesterase Purine Metabolism [c] : 35cimp + h2o --> h + imp
R_PDE5 Chro.30269 or Chro.60462 3.1.4.17 _3',5'-cyclic-nucleotidephosphodiesterase Purine Metabolism [c] : 35ccmp + h2o --> cmp + h
R_PDE4 Chro.30269 or Chro.60462 3.1.4.17 _3',5'-cyclic-nucleotidephosphodiesterase Purine Metabolism [c] : 35cgmp + h2o --> gmp + h
R_AMPDAm Chro.40214 3.5.4.6 Adenosinemonophosphatedeaminase,mitochondrion Purine Metabolism [c] : amp + h + h2o --> imp + nh4
R_AMPDAg Chro.40214 3.5.4.6 Adenosinemonophosphatedeaminase,glycosome Purine Metabolism [c] : amp + h + h2o --> imp + nh4
R_NTPP9 Chro.10434 or Chro.70577 3.6.1.19 Nucleosidetriphosphatepyrophosphorylase(itp) Purine Metabolism [c] : h2o + itp --> h + imp + ppi
R_NTPP10 Chro.10434 or Chro.70577 3.6.1.19 Nucleosidetriphosphatepyrophosphorylase(ditp) Purine Metabolism [c] : ditp + h2o --> dimp + h + ppi
R_NTPP11 Chro.10434 or Chro.70577 3.6.1.19 Nucleosidetriphosphatepyrophosphorylase(xtp) Purine Metabolism [c] : h2o + xtp --> h + ppi + xmp
R_UTPH2e Chro.60194 3.6.1.5 UTPdiphosphohydrolase Purine Metabolism [e] : udp + h2o --> ump + h + pi
R_GTPH2e Chro.60194 3.6.1.5 GTPdiphosphohydrolase Purine Metabolism [e] : gdp + h2o --> gmp + h + pi
R_ATPH2e Chro.60194 3.6.1.5 ATPdiphosphohydrolase Purine Metabolism [e] : adp + h2o --> amp + h + pi
R_UTPH1e Chro.60194 3.6.1.5 UTPdiphosphohydrolase Purine Metabolism [e] : utp + 2 h2o --> ump + 2 h + 2 pi
R_GTPH1e Chro.60194 3.6.1.5 GTPdiphosphohydrolase Purine Metabolism [e] : gtp + 2 h2o --> gmp + 2 h + 2 pi
R_ATPH1e Chro.60194 3.6.1.5 ATPdiphosphohydrolase Purine Metabolism [e] : atp + 2 h2o --> amp + 2 h + 2 pi
R_NDP3ex Chro.60194 3.6.1.6 nucleoside-diphosphatase(GDP),extracellular Purine Metabolism [e] : gdp + h2o --> gmp + h + pi
R_NDP10ex Chro.60194 3.6.1.6 nucleoside-diphosphatase(IDP),extracellular Purine Metabolism [e] : h2o + idp --> h + imp + pi
R_NDP4 Chro.60194 3.6.1.6 nucleoside-diphosphatase(dGDP) Purine Metabolism [c] : dgdp + h2o --> dgmp + h + pi
R_NDP6 Chro.60194 3.6.1.6 nucleoside-diphosphatase(dCDP) Purine Metabolism [c] : dcdp + h2o --> dcmp + h + pi
R_NDP3 Chro.60194 3.6.1.6 nucleoside-diphosphatase(GDP) Purine Metabolism [c] : gdp + h2o --> gmp + h + pi
R_NDP8 Chro.60194 3.6.1.6 nucleoside-diphosphatase(dUDP) Purine Metabolism [c] : dudp + h2o --> dump + h + pi
R_NDP8ex Chro.60194 3.6.1.6 nucleoside-diphosphatase(UTP),extracellular Purine Metabolism [e] : h2o + utp --> h + pi + udp
R_NDP3g Chro.60194 3.6.1.6 nucleoside-diphosphatase(GDP),Golgi Purine Metabolism [c] : gdp + h2o --> gmp + h + pi
R_NDP7er Chro.60194 3.6.1.6 nucleoside-diphosphatase(UDP),endoplasmicreticulum Purine Metabolism [c] : h2o + udp --> h + pi + ump
R_NDP7ex Chro.60194 3.6.1.6 nucleoside-diphosphatase(UDP),extracellular Purine Metabolism [e] : h2o + udp --> h + pi + ump
R_NDP7g Chro.60194 3.6.1.6 nucleoside-diphosphatase(UDP),Golgiapparatus Purine Metabolism [c] : h2o + udp --> h + pi + ump
R_ADSL2r . 4.3.2.2 adenylosuccinatelyase Purine Metabolism [c] : 25aics <==> aicar + fum
R_ADSL1r . 4.3.2.2 adenylsuccinatelyase Purine Metabolism [c] : dcamp <==> amp + fum
R_ADSL2 . 4.3.2.2 adenylosuccinatelyase Purine Metabolism [c] : 25aics --> aicar + fum
R_ADSL1 . 4.3.2.2 adenylosuccinatelyase Purine Metabolism [c] : dcamp --> amp + fum
R_ADNCYC Chro.50255 or Chro.40352 4.6.1.1 adenylatecyclase Purine Metabolism [c] : atp --> camp + ppi
R_GUACYC Chro.50255 or Chro.30141 or Chro.30329 or Chro.403524.6.1.2 guanylatecyclase Purine Metabolism [c] : gtp --> 35cgmp + ppi
R_GMPS . 6.3.4.1 GMPsynthase Purine Metabolism [c] : atp + nh4 + xmp --> amp + gmp + 2 h + ppi
R_RNDR4 Chro.60090 or Chro.60091 1.17.4.1 ribonucleoside-diphosphatereductase(UDP) Pyrimidine Metabolism [c] : trdrd + udp --> dudp + h2o + trdox
R_RNDR3 Chro.60090 or Chro.60091 1.17.4.1 ribonucleoside-diphosphatereductase(CDP) Pyrimidine Metabolism [c] : cdp + trdrd --> dcdp + h2o + trdox
R_RNDR1 Chro.60090 or Chro.60091 1.17.4.1 ribonucleoside-diphosphatereductase(ADP) Pyrimidine Metabolism [c] : adp + trdrd --> dadp + h2o + trdox
R_RNDR2 Chro.60090 or Chro.60091 1.17.4.1 ribonucleoside-diphosphatereductase(GDP) Pyrimidine Metabolism [c] : gdp + trdrd --> dgdp + h2o + trdox
R_TRDR Chro.20464 1.8.1.9 thioredoxinreductase(NADPH) Pyrimidine Metabolism [c] : h + nadph + trdox --> nadp + trdrd
R_TRDR2 Chro.20464 1.8.1.9 Thioredoxin(ubiquinone10)reductase(NADPH) Pyrimidine Metabolism [c] : h + nadph + q10 --> nadp + q10h2
R_TRDR3 Chro.20464 1.8.1.9 Thioredoxin(ubiquinone10)reductase(NADH) Pyrimidine Metabolism [c] : h + nadh + q10 --> nad + q10h2
R_TMDS Chro.40506 or Chro.30116 2.1.1.45 thymidylatesynthase Pyrimidine Metabolism [c] : dump + mlthf --> dhf + dtmp
R_TMDSf Chro.40506 or Chro.30116 2.1.1.45 thymidylatesynthase(Flavin-dependent) Pyrimidine Metabolism [c] : dump + fmnh2 + mlthf --> dtmp + fmn + thf
R_UPPRTr Chro.10216 2.4.2.9 uracilphosphoribosyltransferase(r) Pyrimidine Metabolism [c] : prpp + ura <==> ppi + ump
R_TMDK1 Chro.50398 or Chro.70052 2.7.1.21 thymidinekinase(ATP:thymidine) Pyrimidine Metabolism [c] : atp + thymd --> adp + dtmp + h
R_URIK2 Chro.10216 or Chro.20045 or Chro.803282.7.1.48 uridinekinase(GTP:Uridine) Pyrimidine Metabolism [c] : gtp + uri --> gdp + h + ump
R_URIK1 Chro.10216 or Chro.20045 or Chro.803282.7.1.48 uridinekinase(ATP:Uridine) Pyrimidine Metabolism [c] : atp + uri --> adp + h + ump
R_CYTK2 . 2.7.4.14 cytidylatekinase(dCMP) Pyrimidine Metabolism [c] : atp + dcmp <==> adp + dcdp
R_UMPK5 . 2.7.4.14 UMPkinase(dATP) Pyrimidine Metabolism [c] : datp + ump <==> dadp + udp
R_CYTK9 . 2.7.4.14 cytidylatekinase(CMP,dCTP) Pyrimidine Metabolism [c] : cmp + dctp <==> cdp + dcdp
R_CYTK8 . 2.7.4.14 cytidylatekinase(CMP,dATP) Pyrimidine Metabolism [c] : cmp + datp <==> cdp + dadp
R_CYTK5 . 2.7.4.14 cytidylatekinase(dCMP) Pyrimidine Metabolism [c] : ctp + dcmp <==> cdp + dcdp
R_CYTK7 . 2.7.4.14 cytidylatekinase(CMP,UTP) Pyrimidine Metabolism [c] : cmp + utp <==> cdp + udp
R_CYTK6 . 2.7.4.14 cytidylatekinase(CMP,CTP) Pyrimidine Metabolism [c] : cmp + ctp <==> 2 cdp
R_CYTK1 . 2.7.4.14 cytidylatekinase(CMP) Pyrimidine Metabolism [c] : atp + cmp <==> adp + cdp
R_UMPK3 . 2.7.4.14 UMPkinase(UTP) Pyrimidine Metabolism [c] : ump + utp <==> 2 udp
R_UMPK2 . 2.7.4.14 UMPkinase(CTP) Pyrimidine Metabolism [c] : ctp + ump <==> cdp + udp
R_UMPK7 . 2.7.4.14 UMPkinase(dGTP) Pyrimidine Metabolism [c] : dgtp + ump <==> dgdp + udp
R_UMPK6 . 2.7.4.14 UMPkinase(dCTP) Pyrimidine Metabolism [c] : dctp + ump <==> dcdp + udp
R_UMPK4 . 2.7.4.14 UMPkinase(GTP) Pyrimidine Metabolism [c] : gtp + ump <==> gdp + udp
R_CYTK11 . 2.7.4.14 cytidylatekinase(dCMP,dGTP) Pyrimidine Metabolism [c] : dcmp + dgtp <==> dcdp + dgdp
R_CYTK10 . 2.7.4.14 cytidylatekinase(CMP,dGTP) Pyrimidine Metabolism [c] : cmp + dgtp <==> cdp + dgdp
R_CYTK13 . 2.7.4.14 cytidylatekinase(dCMP,dATP) Pyrimidine Metabolism [c] : datp + dcmp <==> dadp + dcdp
R_CYTK12 . 2.7.4.14 cytidylatekinase(dCMP,dCTP) Pyrimidine Metabolism [c] : dcmp + dctp <==> 2 dcdp
R_CYTK14 . 2.7.4.14 cytidylatekinase(dCMP,UTP) Pyrimidine Metabolism [c] : dcmp + utp <==> dcdp + udp
R_UMPK . 2.7.4.14 UMPkinase Pyrimidine Metabolism [c] : atp + ump <==> adp + udp
R_DTMPK Chro.50490 2.7.4.9 dTMPkinase Pyrimidine Metabolism [c] : atp + dtmp <==> adp + dtdp
R_DUMPK Chro.50490 2.7.4.9 dUMPkinase Pyrimidine Metabolism [c] : atp + dump <==> adp + dudp
R_DCMPDA Chro.20294 3.5.4.12 dCMPdeaminase Pyrimidine Metabolism [c] : dcmp + h + h2o <==> dump + nh4
R_DCYTD Chro.20294 3.5.4.14 deoxycytidinedeaminase Pyrimidine Metabolism [c] : dcyt + h + h2o --> duri + nh4
R_AP4AH1 . 3.6.1.17 Ap4Ahydrolase,asymmetrically Pyrimidine Metabolism [c] : ap4a + h2o --> amp + atp + 2 h
R_DUTPDP Chro.70577 3.6.1.23 dUTPdiphosphatase Pyrimidine Metabolism [c] : dutp + h2o --> dump + h + ppi
R_YUMPS Chro.20165 or Chro.30435 or Chro.20259 or Chro.80065 or Chro.806024.2.1.70 yUMPsynthetase Pyrimidine Metabolism [c] : r5p + ura <==> h2o + psd5p
R_CBPS . 6.3.5.5 carbamoyl-phosphatesynthase(glutamine-hydrolysing) Pyrimidine Metabolism [c] : 2 atp + gln-L + h2o + hco3 --> 2 adp + cbp + glu-L + 2 h + pi
R_LDH_L Chro.70063 1.1.1.27 L-lactatedehydrogenase Pyruvate Metabolism [c] : lac-L + nad <==> h + nadh + pyr
R_MCLOR Chro.70063 or Chro.70062 1.1.1.27 _3-Mercaptolactate:NAD+oxidoreductase Pyruvate Metabolism [c] : mercplac + nad <==> h + mercppyr + nadh
R_2HBO Chro.70063 or Chro.70062 1.1.1.27 _2-Hydroxybutyrate:NAD+oxidoreductase Pyruvate Metabolism [c] : 2hb + nad <==> 2obut + h + nadh
R_MDH Chro.70063 or Chro.70062 1.1.1.37 malatedehydrogenase Pyruvate Metabolism [c] : mal-L + nad <==> h + nadh + oaa
R_MDHi2 Chro.70063 or Chro.70062 1.1.1.37 malatedehydrogenase(otherdirection) Pyruvate Metabolism [c] : h + nadh + oaa --> mal-L + nad
R_ME1 Chro.50314 1.1.1.38 malicenzyme(NAD) Pyruvate Metabolism [c] : mal-L + nad --> co2 + nadh + pyr
R_ME2 Chro.50314 1.1.1.40 malicenzyme(NADP) Pyruvate Metabolism [c] : mal-L + nadp --> co2 + nadph + pyr
R_MDH2 Chro.80050 1.1.99.16 Malatedehydrogenase(ubiquinone8asacceptor) Pyruvate Metabolism [c] : mal-L + q8 --> oaa + q8h2
R_MDH3 Chro.80050 1.1.99.16 Malatedehydrogenase(menaquinone8asacceptor) Pyruvate Metabolism [c] : mal-L + mqn8 --> mql8 + oaa
R_MDH4 Chro.80050 1.1.99.16 Malatedehydrogenase(menaquinone6asacceptor) Pyruvate Metabolism [c] : mal-L + mqn6 --> mql6 + oaa
R_ACALD Chro.80198 1.2.1.10 acetaldehydedehydrogenase(acetylating) Pyruvate Metabolism [c] : acald + coa + nad <==> accoa + h + nadh
R_PDH Chro.40087 1.2.1.51 pyruvatedehydrogenase Pyruvate Metabolism [c] : coa + nadp + pyr --> accoa + co2 + nadph
R_ACYP_2 Chro.70488 3.6.1.7 acylphosphatase(2) Pyruvate Metabolism [c] : actp + h2o --> ac + h + pi
R_PPC Chro.50389 4.1.1.31 phosphoenolpyruvatecarboxylase Pyruvate Metabolism [c] : co2 + h2o + pep --> h + oaa + pi
R_ACS2 Chro.10418 6.2.1.1 acetyl-CoAsynthase(propionate) Pyruvate Metabolism [c] : atp + coa + ppa --> amp + ppcoa + ppi
R_ACS Chro.10418 6.2.1.1 acetyl-CoAsynthetase Pyruvate Metabolism [c] : ac + atp + coa --> accoa + amp + ppi
Appendix A: Metabolic Network Reactions included in the Model iNV213
R_RDH3a Chro.40258 1.1.1.105 retinoldehydrogenase(11-cis,NADPH) Retinol-Vit A Metabolism [c] : nadp + retinol-cis_DASH_11 <==> h + nadph + retinal-11_DASH_cis
R_RDH1a Chro.40258 1.1.1.105 retinoldehydrogenase(all-trans,NADPH) Retinol-Vit A Metabolism [c] : nadp + retinol <==> h + nadph + retinal
R_RDH2a Chro.40258 1.1.1.105 retinoldehydrogenase(9-cis,NADPH) Retinol-Vit A Metabolism [c] : nadp + retinol-9_DASH_cis <==> h + nadph + retinal-cis_DASH_9
R_RDH1 Chro.40258 1.1.1.105 retinoldehydrogenase(all-trans) Retinol-Vit A Metabolism [c] : nad + retinol <==> h + nadh + retinal
R_RDH3 Chro.40258 1.1.1.105 retinoldehydrogenase(11-cis,NADH) Retinol-Vit A Metabolism [c] : nad + retinol-cis_DASH_11 <==> h + nadh + retinal-11_DASH_cis
R_RDH2 Chro.40258 1.1.1.105 retinoldehydrogenase(9-cis,NADH) Retinol-Vit A Metabolism [c] : nad + retinol-9_DASH_cis <==> h + nadh + retinal-cis_DASH_9
R_RDH4 Chro.40258 1.1.1.105 retinoldehydrogenase(13-cis,NADH) Retinol-Vit A Metabolism [c] : nad + retinol-cis_DASH_13 <==> h + nadh + retinal-cis_DASH_13
R_RBFSb Chro.80106 2.5.1.9 riboflavinsynthase Riboflavin Metabolism-Vit B2 [c] : 2 dmlz --> 4r5au + ribflv
R_RBFSa Chro.80106 2.5.1.9 riboflavinsynthase Riboflavin Metabolism-Vit B3 [c] : 4r5au + db4p --> dmlz + 2 h2o + pi
R_ACP1_LPAREN_FMN_RPAREN_Chro.20071 or Chro.80016 or Chro.70489 or Chro.701773.1.3.2 acidphosphatase(FMN) Riboflavin Metabolism-Vit B4 [c] : fmn + h2o --> pi + ribflv
R_SULR Chro.40087 1.8.2.2 sulfitereductase(NADPH2) Selenoamino acid metabolism [c] : 3 h2o + h2s + 3 nadp <==> 5 h + 3 nadph + so3
R_SEAHCYSHYD Chro.30017 3.3.1.1 Se-Adenosylselenohomocysteinehydrolase Selenoamino acid metabolism [c] : h2o + seahcys --> adn + selhcys
R_SIAASE . 3.2.1.18 sialidase Sphingoglycolipid Metabolism [c] : 2 h2o + s2l2n2m2mn --> 2 acnam + l2n2m2mn
R_UDPGDr Chro.80111 1.1.1.22 UDPglucose6-dehydrogenase Starch and Sucrose Metabolism [c] : h2o + 2 nad + udpg <==> 3 h + 2 nadh + udpglcur
R_GLCP Chro.60284 2.4.1.1 glycogenphosphorylase Starch and Sucrose Metabolism [c] : glycogen + pi --> g1p
R_GLPASE2 Chro.60284 2.4.1.1 glycogenphosphorylase(amyls->glc-D) Starch and Sucrose Metabolism [c] : glygn3 + 7 h2o --> Tyr-ggn + 7 glc-D
R_GLPASE1 Chro.60284 2.4.1.1 glycogenphosphorylase(glygn2->dxtrn) Starch and Sucrose Metabolism [c] : glygn2 + 3 pi --> dxtrn + 3 g1p
R_TRE6PS Chro.80565 2.4.1.15 alpha,alpha-trehalose-phosphatesynthase(UDP-forming) Starch and Sucrose Metabolism [c] : g6p + udpg --> h + tre6p + udp
R_GBEZ Chro.60381 2.4.1.18 _1,4-alpha-glucanbranchingenzyme Starch and Sucrose Metabolism [c] : 14glun --> glycogen + h2o
R_GLBRAN Chro.60381 2.4.1.18 _1,4-alpha-glucanbranchingenzyme(glygn1->glygn2) Starch and Sucrose Metabolism [c] : glygn1 --> glygn2
R_AMALT1 Chro.60114 2.4.1.25 Amylomaltase(maltotriose) Starch and Sucrose Metabolism [c] : malt + malttr --> glc-D + maltttr
R_AMALT2 Chro.60114 2.4.1.25 Amylomaltase(maltotetraose) Starch and Sucrose Metabolism [c] : malt + maltttr --> glc-D + maltpt
R_AMALT3 Chro.60114 2.4.1.25 Amylomaltase(maltopentaose) Starch and Sucrose Metabolism [c] : malt + maltpt --> glc-D + malthx
R_AMALT4 Chro.60114 2.4.1.25 Amylomaltase(maltohexaose) Starch and Sucrose Metabolism [c] : malt + malthx --> glc-D + malthp
R_AMY2e Chro.80574 or Chro.50082 or Chro.60381 or Chro.604293.2.1.1 alpha-amylase,extracellular(glygn2->glygn4) Starch and Sucrose Metabolism [e] : glygn2 + 8 h2o --> 8 glc-D + glygn4
R_AMY1e Chro.80574 or Chro.50082 or Chro.60381 or Chro.604293.2.1.1 alpha-amylase,extracellular(strch1->strch2) Starch and Sucrose Metabolism [e] : 8 h2o + strch1 --> 8 glc-D + strch2
R_GLCGSD Chro.80574 or Chro.70613 or Chro.802063.2.1.3 glucan1,4-alpha-glucosidase Starch and Sucrose Metabolism [c] : glycogen + h2o --> glc-D
R_GLDBRAN Chro.60114 3.2.1.33 glycogendebranchingenzyme Starch and Sucrose Metabolism [c] : dxtrn + h2o --> glc-D + glygn3
R_PGI3 Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Starch and Sucrose Metabolism [c] : g6p-A <==> f6p
R_PGI2 Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Starch and Sucrose Metabolism [c] : g6p-A <==> g6p-B
R_PGI1 Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Starch and Sucrose Metabolism [c] : g6p-B <==> f6p
R_DXPRIi . 1.1.1.267 _1-deoxy-D-xylulosereductoisomerase Sterol Biosynthesis [c] : dxyl5p + h + nadph --> 2me4p + nadp
R_IPDDI . 5.3.3.2 isopentenyl-diphosphateD-isomerase Sterol Biosynthesis [c] : ipdp <==> dmpp
R_DMATT Chro.40285 2.5.1.1 dimethylallyltranstransferase Terpenoid Biosynthesis [c] : dmpp + ipdp --> grdp + ppi
R_GRTT Chro.40285 2.5.1.10 geranyltranstransferase Terpenoid Biosynthesis [c] : grdp + ipdp --> frdp + ppi
R_SQLS Chro.10227 2.5.1.21 Squalenesynthase Terpenoid Biosynthesis [c] : 2 frdp + h + nadph --> nadp + 2 ppi + sql
R_H2Ot . . H2Otransportviadiffusion Transport, Extracellular h2o[e] <==> h2o[c]
R_CYSt2r . Transport, Extracellular cys-L[e] + h[e] <==> cys-L[c] + h[c]
R_METt2r Transport, Extracellular h[e] + met-L[e] <==> h[c] + met-L[c]
R_GLNt2r Transport, Extracellular gln-L[e] + h[e] <==> gln-L[c] + h[c]
R_ILEt2r Transport, Extracellular h[e] + ile-L[e] <==> h[c] + ile-L[c]
R_LEUt2r Transport, Extracellular h[e] + leu-L[e] <==> h[c] + leu-L[c]
R_SULabc Transport, Extracellular atp[c] + h2o[c] + so4[e] --> adp[c] + h[c] + pi[c] + so4[c]
R_PROt2r Transport, Extracellular h[e] + pro-L[e] <==> h[c] + pro-L[c]
R_ARGt2r Transport, Extracellular arg-L[e] + h[e] <==> arg-L[c] + h[c]
R_ASPt2r Transport, Extracellular asp-L[e] + h[e] <==> asp-L[c] + h[c]
R_ALAt2 Transport, Extracellular ala-L[e] + h[e] --> ala-L[c] + h[c]
R_HISt2r Transport, Extracellular h[e] + his-L[e] <==> h[c] + his-L[c]
R_LYSt2r Transport, Extracellular h[e] + lys-L[e] <==> h[c] + lys-L[c]
R_SERt2r Transport, Extracellular h[e] + ser-L[e] <==> h[c] + ser-L[c]
R_THRt2 Transport, Extracellular h[e] + thr-L[e] --> h[c] + thr-L[c]
R_TRPt2r Transport, Extracellular h[e] + trp-L[e] <==> h[c] + trp-L[c]
R_TYRt2r Transport, Extracellular h[e] + tyr-L[e] <==> h[c] + tyr-L[c]
R_VALt2r Transport, Extracellular h[e] + val-L[e] <==> h[c] + val-L[c]
R_PIt2 Transport, Extracellular h[e] + pi[e] <==> h[c] + pi[c]
R_CMPtrans Transport, Extracellular cmp[e] + h[e] --> cmp[c] + h[c]
R_AMPtrans Transport, Extracellular amp[e] + h[e] --> amp[c] + h[c]
R_GMPtrans Transport, Extracellular gmp[e] + h[e] --> gmp[c] + h[c]
R_GLCt1r Transport, Extracellular glc-D[e] <==> glc-D[c]
R_CO2t Transport, Extracellular co2[e] <==> co2[c]
R_NH4t Transport, Extracellular nh4[e] <==> nh4[c]
R_PHEt2r Transport, Extracellular h[e] + phe-L[e] <==> h[c] + phe-L[c]
R_TRPTRS Chro.70176 6.1.1.2 Tryptophanyl-tRNAsynthetase Tryptophan metabolism [c] : atp + trnatrp + trp-L --> amp + ppi + trptrna
R_ALCD2m Chro.80199 or Chro.80198 1.1.1.1 alcoholdehydrogenase(ethanol),mitochondrial Tyrosine metabolism [c] : etoh + nad <==> acald + h + nadh
R_DOPABMO . 1.14.17.1 dopaminebeta-monooxygenase Tyrosine metabolism [c] : ascb-L + dopa + o2 --> dhdascb + h2o + nrpphr
R_G5SD2 Chro.70551 1.2.1.41 glutamate-5-semialdehydedehydrogenase Urea Cycle and Metabolism of Amino Groups[c] : glu5p + h + nadh --> glu5sa + nad + pi
R_G5SD Chro.70551 1.2.1.41 glutamate-5-semialdehydedehydrogenase Urea Cycle and Metabolism of Amino Groups[c] : glu5p + h + nadph --> glu5sa + nadp + pi
R_GLU5K Chro.70551 or Chro.20246 2.7.2.11 glutamate5-kinase Urea Cycle and Metabolism of Amino Groups[c] : atp + glu-L --> adp + glu5p
R_OIVD2 . 1.2.4.4 R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxobutanoate_Valine, Le ci e, and Isoleucine Biosynthesis[c] : 1.0 3mob + 1.0 coa + 1.0 nad --> 1.0 co2 + 1.0 ibcoa + 1.0 nadh
R_OIVD3 . 1.2.4.4 R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxopentanoate_Valine, Leucine, nd Isoleucine Biosynthesis[c] : 1.0 3mop + 1.0 coa + 1.0 nad --> 1.0 2mbcoa + 1.0 co2 + 1.0 nadh
R_LEUTRS Chro.50330 or Chro.50331 6.1.1.4 Leucyl-tRNAsynthetase Valine, Leucine, and Isoleucine Biosynthesis[c] : atp + leu-L + trnaleu --> amp + leutrna + ppi
R_ILETRS Chro.30434 6.1.1.5 Isoleucyl-tRNAsynthetase Valine, Leucine, and Isoleucine Biosynthesis[c] : atp + ile-L + trnaile --> amp + iletrna + ppi
R_VALTRS Chro.80361 6.1.1.9 Valyl-tRNAsynthetase Valine, Leucine, and Isoleucine Biosynthesis[c] : atp + trnaval + val-L --> amp + ppi + valtrna
Appendix B: Gap Analysis Results
REACTION IDs ENZYME NAME PATHWAY EC NUMBER REACTION ADDED THROUGH GAP ANALYSIS
R_BIOMASS biomass Biomass . [c] : 0.257980584 ala-L + 0.176597196 arg-L + 0.218152121 asn-L + 0.230278549 asp-L + 0.047389692 cys-L + 0.308171564 glu-L + 0.103857352 gln-L + 0.270219364 gly + 0.057785913 his-L + 0.343142715 ile-L + 0.350014856 leu-L + 0.327413561 lys-L + 0.101531685 met-L + 0.171391596 phe-L + 0.137139492 pro-L + 0.244438532 ser-L + 0.203965923 thr-L + 0.035839999 trp-L + 0.170934701 tyr-L + 0.287641274 val-L + 0.017366666 datp + 0.009566749 dctp + 0.009566749 dgtp + 0.017366666 dttp + 0.0394 ctp + 0.0003 cdp + 0.001 cmp + 0.0415 utp + 105.0535 atp + 0.0047 amp + 0.0674 gtp + 0.0002 gdp + 0.0005 gmp + 0.0009 ppi + 0.0162 nad + 0.0009 nadp + 0.0002 nadph + 0.008562798 m12dg_CT + 0.011044141 d12dg_CT + 0.006631063 t12dg_CT + 0.000458142 cdlp_CT + 0.017672003 pgly_CT + 0.002174587 lysylpgly_CT + 0.05622271 psetha_CT --> 105.0535 pi + 105.0535 h + 105.0509 adp
R_UAG4E R_UDP_N_acetylglucosamine_4_epimerase Aminosugar Metabolism 5.1.3.7 [c] : 1.0 uacgam --> 1.0 uacgala
R_DXPRIi _1-deoxy-D-xylulosereductoisomerase Biosyhthesis of Steroids 1.1.1.267 [c] : dxyl5p + h + nadph --> 2me4p + nadp
R_MECDPS _2-C-methyl-D-erythritol2,4-cyclodiphosphatesynthase Biosyhthesis of Steroids 4.6.1.12 [c] : 2p4c2me --> 2mecdp + cmp
R_IPDDI isopentenyl-diphosphateD-isomerase Biosyhthesis of Steroids 5.3.3.2 [c] : ipdp <==> dmpp
R_DXPS _1-deoxy-D-xylulose5-phosphatesynthase Biosynthesis of Steroids 2.2.1.7 [c] : g3p + h + pyr --> co2 + dxyl5p
R_CDPMEK _4-(cytidine5'-diphospho)-2-C-methyl-D-erythritolkinase Biosynthesis of Steroids 2.7.1.148 [c] : 4c2me + atp --> 2p4c2me + adp + h
R_MEPCT _2-C-methyl-D-erythritol4-phosphatecytidylyltransferase Biosynthesis of Steroids 2.7.7.60 [c] : 2me4p + ctp + h --> 4c2me + ppi
R_KAS2 R_b_ketoacyl_synthetase__n_C140_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 accoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 12.0 nadp + 1.0 ttdca
R_KAS8 R_b_ketoacyl_synthetase__palmitate__n_C160_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 accoa + 20.0 h + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdca + 14.0 nadp
R_KAS13 R_b_ketoacyl_synthetase__n_C180_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 accoa + 23.0 h + 8.0 malcoa + 16.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 16.0 nadp + 1.0 ocdca
R_KAS141 R_b_ketoacyl_synthetase__n_C141_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 accoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 11.0 nadp + 1.0 ttdce
R_KAS7 R_b_ketoacyl_synthetase__n_C161_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 accoa + 19.0 h + 7.0 malcoa + 13.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + 1.0 hdcea + 13.0 nadp
R_KAS17 R_b_ketoacyl_synthetase__n_C181_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 accoa + 22.0 h + 8.0 malcoa + 15.0 nadph --> 8.0 co2 + 9.0 coa + 7.0 h2o + 15.0 nadp + 1.0 ocdcea
R_KAS100iso R_b_ketoacyl_synthetase__branched(iso)_C100 Fatty Acid  Biosynthesis 2.3.1.41 [c] : 8.0 h + 1.0 ibcoa + 3.0 malcoa + 6.0 nadph --> 3.0 co2 + 4.0 coa + 1.0 dca + 2.0 h2o + 6.0 nadp
R_KAS130iso R_b_ketoacyl_synthetase__branched(iso)_C130 Fatty Acid  Biosynthesis 2.3.1.41 [c] : 11.0 h + 1.0 ivcoa + 4.0 malcoa + 8.0 nadph --> 4.0 co2 + 5.0 coa + 1.0 trdca + 3.0 h2o + 8.0 nadp
R_KAS1 R_b_ketoacyl_synthetase__Iso_C140_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 14.0 h + 1.0 ibcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa1 + 4.0 h2o + 10.0 nadp
R_KAS3 R_b_ketoacyl_synthetase__Iso_C150_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 14.0 h + 1.0 ivcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa3 + 4.0 h2o + 10.0 nadp
R_KAS6 R_b_ketoacyl_synthetase__Iso_C160_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 17.0 h + 1.0 ibcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa6 + 5.0 h2o + 12.0 nadp
R_KAS11 R_b_ketoacyl_synthetase__Iso_C170_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 17.0 h + 1.0 ivcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa11 + 5.0 h2o + 12.0 nadp
R_KAS180iso R_b_ketoacyl_synthetase__Iso_C180_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 20.0 h + 1.0 ibcoa + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 1.0 ocdcaiso + 6.0 h2o + 14.0 nadp
R_KAS5 R_b_ketoacyl_synthetase__Iso_C161_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 16.0 h + 1.0 ibcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa5 + 5.0 h2o + 11.0 nadp
R_KAS9 R_b_ketoacyl_synthetase__Iso_C171_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 16.0 h + 1.0 ivcoa + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa9 + 5.0 h2o + 11.0 nadp
R_KAS4 R_b_ketoacyl_synthetase__Anteiso_C150_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 2mbcoa + 14.0 h + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + 1.0 fa4 + 4.0 h2o + 10.0 nadp
R_KAS12 R_b_ketoacyl_synthetase__Anteiso_C170_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 2mbcoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa12 + 5.0 h2o + 12.0 nadp
R_KAS10 R_b_ketoacyl_synthetase__Anteiso_C171_ Fatty Acid  Biosynthesis 2.3.1.41 [c] : 1.0 2mbcoa + 16.0 h + 6.0 malcoa + 11.0 nadph --> 6.0 co2 + 7.0 coa + 1.0 fa10 + 5.0 h2o + 11.0 nadp
R_MAN1PT2r mannose-1-phosphateguanylyltransferase(GDP)reversible Fructose and Mannose Metabolism 2.7.7.22 [c] : gdp + h + man1p <==> gdpmann + pi
R_PLA2_2 phospholipaseA2 Glycerophospholipid Metabolism 3.1.1.4 [c] : h2o + pchol_hs --> Rtotal2 + h + lpchol_hs
R_G3PCT R_glycerol_3_phosphate_cytidylyltransferase Glycerophospholipid Metabolism 2.7.7.39 [c] : 1.0 ctp + 1.0 glyc3p + 1.0 h --> 1.0 cdpglyc + 1.0 ppi
R_CDGPT_CT R_CDPdiacylglycerolsn_glycerol_3_phosphate_3_phosphatidyltransferaseGlyc ophospholipid Metabolism 2.7.8.5 [c] : 1.0 cdpdag_CT + 1.0 glyc3p --> 1.0 cmp + 1.0 h + 1.0 pglyp_CT
R_PGPPH_CT R_Phosphatidylglycerophosphate_phosphohydrolase Glycerophospholipid Metabolism 3.1.3.27 [c] : 1.0 h2o + 1.0 pglyp_CT --> 1.0 pgly_CT + 1.0 pi
R_PAP_CT R_phosphatidic_acid_phosphatase Glycerophospholipid Metabolism 3.1.3.4 [c] : 1.0 12dag3p_CT + 1.0 h2o --> 1.0 12dgr_CT + 1.0 pi
R_GLUK Glucokinase Glycolysis/Gluconeogenesis 2.7.1.2 [c] : atp + glc-D --> adp + g6p-B + h
R_G3POA_CT R_glycerol_3_phosphate_O_acyltransferase Miscellaneous . [c] : 1.0 glyc3p + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 pmtcoa + 0.1334 fa12coa + 0.1255 hdcoa + 0.0479 strcoaiso + 0.0137 strcoa --> 1.0 1ag3p_CT + 1.0 coa
R_LYSLG_CT R_lysylphosphatidylglycerol_synthesis Miscellaneous . [c] : 1.0 atp + 1.0 lys-L + 1.0 pgly_CT --> 1.0 amp + 1.0 h + 1.0 lysylpgly_CT + 1.0 ppi
R_UGT_CT R_UDP_glucosyltransferase__diglucosyl_ Miscellaneous . [c] : 1.0 12dgr_CT + 2.0 udpg --> 1.0 d12dg_CT + 2.0 h + 2.0 udp
R_UGT1_CT R_UDP_glucosyltransferase__monoglucosyl_ Miscellaneous . [c] : 1.0 12dgr_CT + 1.0 udpg --> 1.0 h + 1.0 m12dg_CT + 1.0 udp
R_UGT2_CT R_UDP_glucosyltransferase__triglucosyl_ Miscellaneous . [c] : 1.0 12dgr_CT + 3.0 udpg --> 3.0 h + 1.0 t12dg_CT + 3.0 udp
R_LIPO1S24_CT R_lipoteichoic_acid_synthesis__n24___linked__glucose_substitutedMiscellaneous . [c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 udpg --> 24.0 cmp + 48.0 h + 1.0 lipo1_24_CT + 24.0 udp
R_LIPO2S24_CT R_lipoteichoic_acid_synthesis__n24___linked__N_acetylglucosamine_substitutedMisc llaneous . [c] : 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 uacgam --> 24.0 cmp + 48.0 h + 1.0 lipo2_24_CT + 24.0 udp
R_LIPO3S24_CT R_lipoteichoic_acid_synthesis__n24___unliked__D_alanine_substitutedMiscellaneous . [c] : 24.0 ala-D + 24.0 atp + 24.0 cdpglyc + 1.0 d12dg_CT + 24.0 h2o --> 24.0 amp + 24.0 cmp + 48.0 h + 1.0 lipo3_24_CT + 24.0 ppi
R_LIPO4S24_CT R_lipoteichoic_acid_synthesis__n24___linked__unsubstituted Miscellaneous . [c] : 24.0 cdpglyc + 1.0 d12dg_CT --> 24.0 cmp + 24.0 h + 1.0 lipo4_24_CT
R_TECA1S45 R_glycerol_teichoic_acid__n45___unlinked__unsubstituted Miscellaneous . [c] : 45.0 cdpglyc + 1.0 uacgam + 1.0 uacmam --> 45.0 cmp + 1.0 gtca1_45_CT + 46.0 h + 1.0 udp + 1.0 ump
R_TECA2S45 R_glycerol_teichoic_acid__n45___unlinked__D_ala_substitutedMiscellaneous . [c] : 45.0 ala-D + 45.0 atp + 45.0 cdpglyc + 45.0 h2o + 1.0 uacgam + 1.0 uacmam --> 45.0 amp + 45.0 cmp + 1.0 gtca2_45_CT + 91.0 h + 45.0 ppi + 1.0 udp + 1.0 ump
R_TECA3S45 R_glycerol_teichoic_acid__n45___unlinked__glucose_substitutedMiscellaneous . [c] : 45.0 cdpglyc + 1.0 h2o + 1.0 uacgam + 1.0 uacmam + 45.0 udpg --> 45.0 cmp + 1.0 gtca3_45_CT + 91.0 h + 46.0 udp + 1.0 ump
R_TECA4S_CT R_minor_teichoic_acid_synthesis__n30_ Miscellaneous . [c] : 30.0 h2o + 30.0 uacgala + 30.0 udpg --> 60.0 h + 1.0 tcam_CT + 30.0 udp + 30.0 ump
R_TEICH45 R_teichuronic_acid__n45___unlinked__GalNAc_GlcA_repeated Miscellaneous . [c] : 45.0 uacgala + 45.0 udpglcur <==> 45.0 h + 1.0 teich_45_CT + 45.0 udp + 45.0 ump
R_UAGPT3 R_UDP_N_acetylglucosamine_N_acetylmuramyl__pentapeptide_pyrophosphoryl_undecaprenol_N_acetylglucosamine_transferaseMiscellaneous . [c] : 1.0 u cgam + 1.0 uagmda --> 1.0 h + 1.0 uaagmda + 1.0 udp
R_PPTGS_CT R_Peptidoglycan_subunit_synthesis Miscellaneous . [c] : 1.0 uaagmda --> 1.0 h + 1.0 peptido_CT + 1.0 udcpdp
R_FRTT R_farnesyltranstransferase Miscellaneous . [c] : 1.0 frdp + 1.0 ipdp --> 1.0 ggdp + 1.0 ppi
R_GGTT R_geranylgeranyltranstransferase Miscellaneous . [c] : 1.0 ggdp + 1.0 ipdp --> 1.0 pendp + 1.0 ppi
R_PPTT R_trans_pentaprenyltranstransferase Miscellaneous . [c] : 1.0 ipdp + 1.0 pendp --> 1.0 hexdp + 1.0 ppi
R_HEXTT R_trans_hexaprenyltranstransferase Miscellaneous . [c] : 1.0 hexdp + 1.0 ipdp --> 1.0 hepdp + 1.0 ppi
R_ICHORS R_isochorismate_synthase Miscellaneous . [c] : 1.0 chor <==> 1.0 ichor
R_2S6HCCi R_2_succinyl_6_hydroxy_2_4_cyclohexadiene_1_carboxylate_synthaseMiscellaneous . [c] : 1.0 akg + 1.0 h + 1.0 ichor --> 1.0 2shchc + 1.0 co2 + 1.0 pyr
R_SUCBZS R_O_succinylbenzoate_CoA_synthase Miscellaneous . [c] : 1.0 2shchc --> 1.0 h2o + 1.0 sucbz
R_SUCBZL R_o_succinylbenzoate_CoA_ligase Miscellaneous . [c] : 1.0 atp + 1.0 coa + 1.0 sucbz --> 1.0 amp + 1.0 ppi + 1.0 sbzcoa
R_NPHS R_naphthoate_synthase Miscellaneous . [c] : 1.0 sbzcoa --> 1.0 coa + 1.0 dhna
R_DHNAOT7 R_1_4_dihydroxy_2_naphthoate_octaprenyltransferase Miscellaneous . [c] : 1.0 dhna + 1.0 hepdp + 1.0 nad --> 1.0 2dmmq7 + 1.0 co2 + 1.0 nadh + 1.0 ppi
R_AMMQT7 R_S_adenosylmethione2_demthylmenaquinone_methyltransferase__menaquinone_7_Miscellaneous . [c] : 1.0 2dmmq7 + 1.0 amet + 1.0 nadph --> 1.0 ahcys + 1.0 mql7 + 1.0 nadp
R_H2CO3D2 carboxylicaciddissociation Miscellaneous . [c] : h + hco3 <==> h2co3
R_MECDPDH _2C-methyl-D-erythritol2,4cyclodiphosphatedehydratase Miscellaneous 1.17.4.3 [c] : 2mecdp + h --> h2mb4p + h2o
R_CLPNS2_CT R_cardiolipin_synthase Miscellaneous 2.7.8.- [c] : 2.0 pgly_CT --> 1.0 cdlp_CT + 1.0 glyc
R_UPP3S uroporphyrinogen-IIIsynthase Porphyrin and chlorophyll metabolism 4.2.1.75 [c] : hmbil --> h2o + uppg3
R_ADSL2r adenylosuccinatelyase Purine Metabolism 4.3.2.2 [c] : 25aics <==> aicar + fum
R_ADSL1r adenylsuccinatelyase Purine Metabolism 4.3.2.2 [c] : dcamp <==> amp + fum
R_ADSL2 adenylosuccinatelyase Purine Metabolism 4.3.2.2 [c] : 25aics --> aicar + fum
R_ADSL1 adenylosuccinatelyase Purine Metabolism 4.3.2.2 [c] : dcamp --> amp + fum
R_GMPS GMPsynthase Purine Metabolism 6.3.4.1 [c] : atp + nh4 + xmp --> amp + gmp + 2 h + ppi
R_CYTK2 cytidylatekinase(dCMP) Pyrimidine Metabolism 2.7.4.14 [c] : atp + dcmp <==> adp + dcdp
R_UMPK5 UMPkinase(dATP) Pyrimidine Metabolism 2.7.4.14 [c] : datp + ump <==> dadp + udp
R_CYTK9 cytidylatekinase(CMP,dCTP) Pyrimidine Metabolism 2.7.4.14 [c] : cmp + dctp <==> cdp + dcdp
R_CYTK8 cytidylatekinase(CMP,dATP) Pyrimidine Metabolism 2.7.4.14 [c] : cmp + datp <==> cdp + dadp
R_CYTK5 cytidylatekinase(dCMP) Pyrimidine Metabolism 2.7.4.14 [c] : ctp + dcmp <==> cdp + dcdp
R_CYTK7 cytidylatekinase(CMP,UTP) Pyrimidine Metabolism 2.7.4.14 [c] : cmp + utp <==> cdp + udp
R_CYTK6 cytidylatekinase(CMP,CTP) Pyrimidine Metabolism 2.7.4.14 [c] : cmp + ctp <==> 2 cdp
R_CYTK1 cytidylatekinase(CMP) Pyrimidine Metabolism 2.7.4.14 [c] : atp + cmp <==> adp + cdp
R_UMPK3 UMPkinase(UTP) Pyrimidine Metabolism 2.7.4.14 [c] : ump + utp <==> 2 udp
R_UMPK2 UMPkinase(CTP) Pyrimidine Metabolism 2.7.4.14 [c] : ctp + ump <==> cdp + udp
R_UMPK7 UMPkinase(dGTP) Pyrimidine Metabolism 2.7.4.14 [c] : dgtp + ump <==> dgdp + udp
R_UMPK6 UMPkinase(dCTP) Pyrimidine Metabolism 2.7.4.14 [c] : dctp + ump <==> dcdp + udp
R_UMPK4 UMPkinase(GTP) Pyrimidine Metabolism 2.7.4.14 [c] : gtp + ump <==> gdp + udp
R_CYTK11 cytidylatekinase(dCMP,dGTP) Pyrimidine Metabolism 2.7.4.14 [c] : dcmp + dgtp <==> dcdp + dgdp
R_CYTK10 cytidylatekinase(CMP,dGTP) Pyrimidine Metabolism 2.7.4.14 [c] : cmp + dgtp <==> cdp + dgdp
R_CYTK13 cytidylatekinase(dCMP,dATP) Pyrimidine Metabolism 2.7.4.14 [c] : datp + dcmp <==> dadp + dcdp
R_CYTK12 cytidylatekinase(dCMP,dCTP) Pyrimidine Metabolism 2.7.4.14 [c] : dcmp + dctp <==> 2 dcdp
R_CYTK14 cytidylatekinase(dCMP,UTP) Pyrimidine Metabolism 2.7.4.14 [c] : dcmp + utp <==> dcdp + udp
R_UMPK UMPkinase Pyrimidine Metabolism 2.7.4.14 [c] : atp + ump <==> adp + udp
R_AP4AH1 Ap4Ahydrolase,asymmetrically Pyrimidine Metabolism 3.6.1.17 [c] : ap4a + h2o --> amp + atp + 2 h
R_CBPS carbamoyl-phosphatesynthase(glutamine-hydrolysing) Pyrimidine Metabolism 6.3.5.5 [c] : 2 atp + gln-L + h2o + hco3 --> 2 adp + cbp + glu-L + 2 h + pi
R_SIAASE sialidase Sphingoglycolipid Metabolism 3.2.1.18 [c] : 2 h2o + s2l2n2m2mn --> 2 acnam + l2n2m2mn
R_H2Ot H2Otransportviadiffusion Transport, Extracellular . h2o[e] <==> h2o[c]
R_CYSt2r Transport, Extracellular cys-L[e] + h[e] <==> cys-L[c] + h[c]
R_DOPABMO dopaminebeta-monooxygenase Tyrosine metabolism 1.14.17.1 [c] : ascb-L + dopa + o2 --> dhdascb + h2o + nrpphr
R_OIVD2 R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxobutanoate_Valine, Leucine, and Isoleucine Biosynthesis1.2.4.4 [c] : 1.0 3mob + 1.0 coa + 1.0 nad --> 1.0 co2 + 1.0 ibcoa + 1.0 nadh
R_OIVD3 R_2_oxoisovalerate_dehydrogenase__acylating_3_methyl_2_oxopentanoate_Vali e, Leucine, and Isoleucine Biosynthesis1.2.4.4 [c] : 1.0 3mop + 1.0 coa + 1.0 nad --> 1.0 2mbcoa + 1.0 co2 + 1.0 nadh
While integrating proteomic data, following highlighted reaction that were inserted through Gap Analysis algorithm were later found to be existing in oocyst stage of parasite
hence not included in the figure 8, gap analysis reaction classification
Appendix C: Predicted Essential Reactions in the Model
REACTION IDs ENZYME NAME PATHWAY EC NUMBER GENE IDs REACTION
R_biomass_target Biomass Rxn Biomass Objective . [c] : 0.257980584 ala-L + 0.176597196 arg-L + 0.218152121 asn-L + 0.230278549 asp-L + 0.047389692 cys-L + 0.308171564 glu-L + 0.103857352 gln-L + 0.270219364 gly + 0.057785913 his-L + 0.343142715 ile-L + 0.350014856 leu-L + 0.327413561 lys-L + 0.101531685 met-L + 0.171391596 phe-L + 0.137139492 pro-L + 0.244438532 ser-L + 0.203965923 thr-L + 0.035839999 trp-L + 0.170934701 tyr-L + 0.287641274 val-L + 0.017366666 datp + 0.009566749 dctp + 0.009566749 dgtp + 0.017366666 dttp + 0.0394 ctp + 0.0003 cdp + 0.001 cmp + 0.0415 utp + 105.0535 atp + 0.0047 amp + 0.0674 gtp + 0.0002 gdp + 0.0005 gmp + 0.0009 ppi + 0.0162 nad + 0.0009 nadp + 0.0002 nadph + 0.008562798 m12dg_CT + 0.011044141 d12dg_CT + 0.006631063 t12dg_CT + 0.000458142 cdlp_CT + 0.017672003 pgly_CT + 0.002174587 lysylpgly_CT + 0.05622271 psetha_CT --> 105.0535 pi + 105.0535 h + 105.0509 adp
R_G3POA_CT R_glycerol_3_phosphate_O_acyltransferase. . [c] : glyc3p + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 pmtcoa + 0.1334 fa12coa + 0.1255 hdcoa + 0.0479 strcoaiso + 0.0137 strcoa --> 1ag3p_CT + coa
R_LYSLG_CT R_lysylphosphatidylglycerol_synthesis . . [c] : atp + lys-L + pgly_CT --> amp + h + lysylpgly_CT + ppi
R_UGT_CT R_UDP_glucosyltransferase__diglucosyl_. . [c] : 12dgr_CT + 2.0 udpg --> d12dg_CT + 2.0 h + 2.0 udp
R_UGT1_CT R_UDP_glucosyltransferase__monoglucosyl_. . [c] : 12dgr_CT + udpg --> h + m12dg_CT + udp
R_UGT2_CT R_UDP_glucosyltransferase__triglucosyl_. . [c] : 12dgr_CT + 3.0 udpg --> 3.0 h + t12dg_CT + 3.0 udp
R_AGPATr_CT R_1_acylglycerol_3_phosphate_O_acyltransferase. 2.3.1.51 Chro.80165 [c] : 1ag3p_CT + 0.051 dcacoa + 0.022 trdacoa + 0.023 fa1coa + 0.0092 tdcoa + 0.022 ttdcecoa + 0.323 fa6coa + 0.2293 pmtcoa + 0.1334 fa12coa + 0.1255 hdcoa + 0.0479 strcoaiso + 0.0137 strcoa --> 12dag3p_CT + coa
R_PHCYT_CT R_phosphatidate_cytidylyltransferase . 2.7.7.41 Chro.70059 or Chro.20170[c] : 1 dag3p_CT + ctp + h --> cdpdag_CT + ppi
R_CLPNS2_CT R_cardiolipin_synthase . 2.7.8.- [c] : 2.0 pgly_CT --> cdlp_CT + glyc
R_CDPDSP_CT R_CDPdiacylglycerol_serine_O_phosphatidyltransferase. 2.7.8.8 Chro.70250 [c] : cdpdag_CT + ser-L --> cmp + h + ps_CT
R_PSDC_CT R_phosphatidylserine_decarboxylase . 4.1.1.65 Chro.30247 [c] : ps_CT --> co2 + psetha_CT
R_P5CD _1-pyrroline-5-carboxylatedehydrogenaseArginine and Proline Metabolism 1.5.1.12 Chro.60426 or Chro.70551[c] : 1pyr c + 2 h2o + nad --> glu-L + h + nadh
R_PRO1x prolineoxidase(L-proline,NAD) Arginine and Proline Metabolism 1.5.1.2 Chro.60426 [c] : nad + pro-L --> 1pyr5c + 2 h + nadh
R_KAS12 R_b_ketoacyl_synthetase__Anteiso_C170_Fatty Acid Biosynthsis 2.3.1.41 [c] : 2mbcoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + fa12 + 5.0 h2o + 12.0 nadp
R_KAS100iso R_b_ketoacyl_synthetase__branched(iso)_C100Fatty Acid Biosynthsis 2.3.1.41 [c] : 8.0 h + ibcoa + 3.0 malcoa + 6.0 nadph --> 3.0 co2 + 4.0 coa + dca + 2.0 h2o + 6.0 nadp
R_KAS130iso R_b_ketoacyl_synthetase__branched(iso)_C130Fatty Acid Biosynthsis 2.3.1.41 [c] : 11.0 h + ivcoa + 4.0 malcoa + 8.0 nadph --> 4.0 co2 + 5.0 coa + trdca + 3.0 h2o + 8.0 nadp
R_KAS1 R_b_ketoacyl_synthetase__Iso_C140_ Fatty Acid Biosynthsis 2.3.1.41 [c] : 14.0 h + ibcoa + 5.0 malcoa + 10.0 nadph --> 5.0 co2 + 6.0 coa + fa1 + 4.0 h2o + 10.0 nadp
R_KAS6 R_b_ketoacyl_synthetase__Iso_C160_ Fatty Acid Biosynthsis 2.3.1.41 [c] : 17.0 h + ibcoa + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + fa6 + 5.0 h2o + 12.0 nadp
R_KAS180iso R_b_ketoacyl_synthetase__Iso_C180_ Fatty Acid Biosynthsis 2.3.1.41 [c] : 20.0 h + ibcoa + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + ocdcaiso + 6.0 h2o + 14.0 nadp
R_KAS7 R_b_ketoacyl_synthetase__n_C161_ Fatty Acid Biosynthsis 2.3.1.41 [c] : accoa + 19.0 h + 7.0 malcoa + 13.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + hdcea + 13.0 nadp
R_KAS8 R_b_ketoacyl_synthetase__palmitate__n_C160_Fatty Acid Biosynthsis 2.3.1.41 [c] : accoa + 20.0 h + 7.0 malcoa + 14.0 nadph --> 7.0 co2 + 8.0 coa + 6.0 h2o + hdca + 14.0 nadp
R_KAS2 R_b_ketoacyl_synthetase__n_C140_ Fatty Acid Biosynthsis 2.3.1.41 [c] : accoa + 17.0 h + 6.0 malcoa + 12.0 nadph --> 6.0 co2 + 7.0 coa + 5.0 h2o + 12.0 nadp + ttdca
R_FACOAL170_anteiso_ R_fatty_acid__CoA_ligase__anteiso_C170_Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30084[c] : atp + coa + fa12 <==> amp + fa12coa + ppi
R_FACOAL100 R_fatty_acid__CoA_ligase__Iso_C100_ Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30085[c] : atp + coa + dca <==> amp + dcacoa + ppi
R_FACOAL130 R_fatty_acid__CoA_ligase__Iso_C130_ Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30086[c] : atp + coa + trdca <==> amp + trdacoa + ppi
R_FACOAL140_ISO_ R_fatty_acid__CoA_ligase__Iso_C140_ Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30087[c] : atp + coa + fa1 <==> amp + fa1coa + ppi
R_FACOAL160_ISO_ R_fatty_acid__CoA_ligase__Iso_C160_ Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30088[c] : atp + coa + fa6 <==> amp + fa6coa + ppi
R_FACOAL180_ISO_ R_fatty_acid__CoA_ligase__Iso_C180_ Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30089[c] : atp + coa + ocdcaiso <==> amp + ppi + strcoaiso
R_FACOAL161 fatty-acid--CoAligase(hexadecenoate) Fatty Acid Biosynthsis 6.2.1.3 Chro.50052 or Chro.30090[c] : atp + coa + hdcea <==> amp + hdcoa + ppi
R_GLNS glutaminesynthetase Glutamate metabolism 6.3.1.2 Chro.60524 [c] : atp + glu-L + nh4 --> adp + gln-L + h + pi
R_G3PD1ir glycerol-3-phosphatedehydrogenase(NAD)Glycerolipid Metabolism 1.1.1.8 Chro.20028 [c] : dhap + h + nadh --> glyc3p + nad
R_CDGPT_CT R_CDPdiacylglycerolsn_glycerol_3_phosphate_3_phosphatidyltransferaseGlycerophospholipid Metabolism 2.7.8.5 [c] : cdpdag_CT + glyc3p --> cmp + h + pglyp_CT
R_PGPPH_CT R_Phosphatidylglycerophosphate_phosphohydrolaseGlyce phospholipid Metabolism 3.1.3.27 [c] : h2o + pglyp_CT --> pgly_CT + pi
R_PAP_CT R_phosphatidic_acid_phosphatase Glycerophospholipid Metabolism 3.1.3.4 [c] : 12dag3p_CT + h2o --> 12dgr_CT + pi
R_GAPD glyceraldehyde-3-phosphatedehydrogenaseGlycolysis/Gluconeogenesis 1.2.1.12 Chro.60434 or Chro.10337[c] : g3p + nad + pi <==> 13dpg + h + nadh
R_PYK pyruvatekinase Glycolysis/Gluconeogenesis 2.7.1.40 Chro.10234 [c] : adp + h + pep --> atp + pyr
R_FBA fructose-bisphosphatealdolase Glycolysis/Gluconeogenesis 4.1.2.13 Chro.10335 [c] : fdp <==> dhap + g3p
R_ENO enolase Glycolysis/Gluconeogenesis 4.2.1.11 Chro.50184 [c] : 2pg <==> h2o + pep
R_PGM phosphoglyceratemutase Glycolysis/Gluconeogenesis 5.4.2.1 Chro.10196 or Chro.70471[c] : 2pg <==> 3pg
R_NADK NADkinase NAD Metabolism 2.7.1.23 Chro.80231 [c] : atp + nad --> adp + h + nadp
R_RNDR4 ribonucleoside-diphosphatereductase(UDP)urine Metabolism 1.17.4.1 Chro.60090 or Chro.60091[c] : trdrd + udp --> dudp + h2o + trdox
R_ADNK2 adenosinekinase Purine Metabolism 2.7.1.20 Chro.20322 [c] : adn + gtp --> adp + gmp + h
R_NDPK4 nucleoside-diphosphatekinase(ATP:dTDP)Purine Metabolism 2.7.4.6 Chro.40275 or Chro.50237 or Chro.40219[c] : atp + dtdp <==> adp + dttp
R_GK1 guanylatekinase(GMP:ATP) Purine Metabolism 2.7.4.8 Chro.70250 [c] : atp + gmp <==> adp + gdp
R_NTD7 5'-nucleotidase(AMP) Purine Metabolism 3.1.3.5 Chro.50026 [c] : amp + h2o --> adn + pi
R_NTD5 5'-nucleotidase(dTMP) Purine Metabolism 3.1.3.5 Chro.50026 [c] : dtmp + h2o --> pi + thymd
R_RNDR2 ribonucleoside-diphosphatereductase(GDP)yrimidine Metabolism 1.17.4.1 Chro.60090 or Chro.60091[c] : gdp + trdrd --> dgdp + h2o + trdox
R_RNDR1 ribonucleoside-diphosphatereductase(ADP)yrimidine Metabolism 1.17.4.1 Chro.60090 or Chro.60091[c] : adp + trdrd --> dadp + h2o + trdox
R_RNDR3 ribonucleoside-diphosphatereductase(CDP)yrimidine Metabolism 1.17.4.1 Chro.60090 or Chro.60091[c] : cdp + trdrd --> dcdp + h2o + trdox
R_TRDR thioredoxinreductase(NADPH) Pyrimidine Metabolism 1.8.1.9 Chro.20464 [c] : h + nadph + trdox --> nadp + trdrd
R_DTMPK dTMPkinase Pyrimidine Metabolism 2.7.4.9 Chro.50490 [c] : atp + dtmp <==> adp + dtdp
R_DCMPDA dCMPdeaminase Pyrimidine Metabolism 3.5.4.12 Chro.20294 [c] : dcmp + h + h2o <==> dump + nh4
Appendix D: Optimization result of oocyst and sporozoite stage data with nodel iNV213
Gene IDs EC Numbers Enzyme Pathway Reaction
Reaction present in oocyst stage only
Chro.40493 2.7.1.107 R_diacylglycerol_kinase . [c] : 12dgr_CT + atp --> 12dag3p_CT + adp + h
Chro.60435 2.7.1.1 hexokinase Glycolysis/Gluconeogenesis [c] : atp + glc-D --> adp + h + g6p
Chro.40330 1.2.1.31 L-aminoadipate-semialdehydedehydrogenase(NADPH) Lysine Biosynthesis [c] : L2aadp + atp + h + nadph --> L2aadp6sa + amp + nadp + ppi
Chro.40330 1.2.1.31 L-aminoadipate-semialdehydedehydrogenase(NADH) Lysine Biosynthesis [c] : L2aadp6sa + h2o + nad --> L2aadp + 2 h + nadh
Chro.40159 3.6.1.1 inorganicdiphosphatase Oxidative Phosphorylation [c] : h2o + ppi --> h + 2 pi
Chro.50026 3.1.3.5 5'-nucleotidase(UMP) Purine Metabolism [c] : h2o + ump --> pi + uri
Chro.50026 3.1.3.5 5'-nucleotidase(AMP) Purine Metabolism [c] : amp + h2o --> adn + pi
Chro.20322 2.7.1.20 adenosinekinase Purine Metabolism [c] : adn + gtp --> adp + gmp + h
Chro.50398 or Chro.700522.7.1 21 thymidinekinase(ATP:thymidine) Pyrimidine Metabolism [c] : atp + thymd --> adp + dtmp + h
Chro.10216 or Chro.20045 or Chro.803282.7.1 48 uridinekinase(ATP:Uridine) Pyrimidine Metabolism [c] : atp + uri --> adp + h + ump
Chro.10216 or Chro.20045 or Chro.803282.7.1 48 uridinekinase(GTP:Uridine) Pyrimidine Metabolism [c] : gtp + uri --> gdp + h + ump
Chro.50389 4.1.1.31 phosphoenolpyruvatecarboxylase Pyruvate Metabolism [c] : co2 + h2o + pep --> h + oaa + pi
Chro.50314 1.1.1.38 malicenzyme(NAD) Pyruvate Metabolism [c] : mal-L + nad --> co2 + nadh + pyr
Chro.50314 1.1.1.40 malicenzyme(NADP) Pyruvate Metabolism [c] : mal-L + nadp --> co2 + nadph + pyr
Reactions presnt in sporozoite stage only
. Glucokinase Glycolysis/Gluconeogenesis [c] : atp + glc-D --> adp + g6p-B + h
Chro.60194 3.6.1.6 nucleoside-diphosphatase(GDP) Nucleotide Salvage Pathway [c] : gdp + h2o --> gmp + h + pi
Chro.20336 5.3.1.9 Glucose-6-phosphateisomerase Pentose Phosphate Pathway [c] : g6p <==> g6p-B
Chro.60194 3.6.1.6 nucleoside-diphosphatase(dCDP) Purine Metabolism [c] : dcdp + h2o --> dcmp + h + pi
Chro.60194 3.6.1.6 nucleoside-diphosphatase(dUDP) Purine Metabolism [c] : dudp + h2o --> dump + h + pi
Chro.60194 3.6.1.6 nucleoside-diphosphatase(UDP) Purine Metabolism [c] : h2o + udp --> h + pi + ump
2.7.4.14 cytidylatekinase(dCMP) Pyrimidine Metabolism [c] : ctp + dcmp <==> cdp + dcdp
Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Starch and Sucrose Metabolism [c] : g6p-A <==> g6p-B
Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Starch and Sucrose Metabolism [c] : g6p-A <==> f6p
Chro.20336 5.3.1.9 glucose-6-phosphateisomerase Starch and Sucrose Metabolism [c] : g6p-B <==> f6p
Reactions commonly present in both the stages
. phosphoglyceratekinase Carbon Fixation [c] : 3pg + atp <==> 13dpg + adp
. triose-phosphateisomerase Fructose and Mannose Metabolism [c] : dhap <==> g3p
. phosphoglyceratekinase Glycolysis/Gluconeogenesis [c] : 3pg + atp <==> 13dpg + adp
. pyruvatedecarboxylase Glycolysis/Gluconeogenesis [c] : h + pyr --> acald + co2
. enolase Glycolysis/Gluconeogenesis [c] : 2pg <==> h2o + pep
. phosphoglyceratemutase Glycolysis/Gluconeogenesis [c] : 2pg <==> 3pg
. glucose-6-phosphateisomerase Glycolysis/Gluconeogenesis [c] : g6p <==> f6p
. glyceraldehyde-3-phosphatedehydrogenase Glycolysis/Gluconeogenesis [c] : g3p + nad + pi <==> 13dpg + h + nadh
. pyruvatekinase Glycolysis/Gluconeogenesis [c] : adp + h + pep --> atp + pyr
. alcoholdehydrogenase(ethanol) Glycolysis/Gluconeogenesis [c] : etoh + nad <==> acald + h + nadh
. fructose-bisphosphatealdolase Glycolysis/Gluconeogenesis [c] : fdp <==> dhap + g3p
. phosphofructokinase,glycosome Glycolysis/Gluconeogenesis [c] : atp + f6p --> adp + fdp + h
. adenylosuccinatelyase IMP Biosynthesis [c] : 25aics --> aicar + fum
. adenylosuccinatelyase Nucleotides [c] : dcamp --> amp + fum
. phosphofructokinase Pentose Phosphate Pathway [c] : atp + f6p --> adp + fdp + h
. adenylosuccinatelyase Purine Metabolism [c] : 25aics <==> aicar + fum
. nucleoside-diphosphatekinase(ATP:dADP) Purine Metabolism [c] : atp + dadp <==> adp + datp
. nucleoside-diphosphatekinase(ATP:dCDP) Purine Metabolism [c] : atp + dcdp <==> adp + dctp
. nucleoside-diphosphatekinase(ATP:dGDP) Purine Metabolism [c] : atp + dgdp <==> adp + dgtp
. nucleoside-diphosphatekinase(ATP:CDP) Purine Metabolism [c] : atp + cdp <==> adp + ctp
. nucleoside-diphosphatekinase(ATP:UDP) Purine Metabolism [c] : atp + udp <==> adp + utp
. adenylsuccinatelyase Purine Metabolism [c] : dcamp <==> amp + fum
. nucleoside-diphosphatekinase(ATP:GDP) Purine Metabolism [c] : atp + gdp <==> adp + gtp
. guanylatekinase(GMP:ATP) Purine Metabolism [c] : atp + gmp <==> adp + gdp
. UMPkinase(CTP) Pyrimidine Metabolism [c] : ctp + ump <==> cdp + udp
. UMPkinase(dGTP) Pyrimidine Metabolism [c] : dgtp + ump <==> dgdp + udp
. UMPkinase Pyrimidine Metabolism [c] : atp + ump <==> adp + udp
. UMPkinase(dCTP) Pyrimidine Metabolism [c] : dctp + ump <==> dcdp + udp
. cytidylatekinase(dCMP) Pyrimidine Metabolism [c] : atp + dcmp <==> adp + dcdp
. cytidylatekinase(CMP,dCTP) Pyrimidine Metabolism [c] : cmp + dctp <==> cdp + dcdp
. cytidylatekinase(CMP,dATP) Pyrimidine Metabolism [c] : cmp + datp <==> cdp + dadp
. cytidylatekinase(CMP,UTP) Pyrimidine Metabolism [c] : cmp + utp <==> cdp + udp
. cytidylatekinase(CMP,CTP) Pyrimidine Metabolism [c] : cmp + ctp <==> 2 cdp
. cytidylatekinase(CMP) Pyrimidine Metabolism [c] : atp + cmp <==> adp + cdp
. UMPkinase(UTP) Pyrimidine Metabolism [c] : ump + utp <==> 2 udp
. UMPkinase(dATP) Pyrimidine Metabolism [c] : datp + ump <==> dadp + udp
. UMPkinase(GTP) Pyrimidine Metabolism [c] : gtp + ump <==> gdp + udp
. cytidylatekinase(dCMP,dGTP) Pyrimidine Metabolism [c] : dcmp + dgtp <==> dcdp + dgdp
. cytidylatekinase(CMP,dGTP) Pyrimidine Metabolism [c] : cmp + dgtp <==> cdp + dgdp
. cytidylatekinase(dCMP,dATP) Pyrimidine Metabolism [c] : datp + dcmp <==> dadp + dcdp
. cytidylatekinase(dCMP,dCTP) Pyrimidine Metabolism [c] : dcmp + dctp <==> 2 dcdp
. cytidylatekinase(dCMP,UTP) Pyrimidine Metabolism [c] : dcmp + utp <==> dcdp + udp
. malatedehydrogenase(otherdirection) Pyruvate Metabolism [c] : h + nadh + oaa --> mal-L + nad
. L-lactatedehydrogenase Pyruvate Metabolism [c] : lac-L + nad <==> h + nadh + pyr
. malatedehydrogenase Pyruvate Metabolism [c] : mal-L + nad <==> h + nadh + oaa
. H2Otransportviadiffusion Transport, Extracellular h2o[e] <==> h2o[c]
. alcoholdehydrogenase(ethanol),mitochondrial Tyrosine metabolism [c] : etoh + nad <==> acald + h + nadh
. glc-D[e] <==> glc-D[c]
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